The Staudinger reaction: a versatile synthetic tool for the construction of β-lactams, heterocycles, and functional organic molecules Authors: Ehsan Ullah Mughal, Nafeesa Naeem, Laiba Iftikhar, Shabnam, Amina Afzaal, H. A. Alrafai, Magdi E. A. Zaki, Amina Sadiq, Maher Fathalla Published: 2026 ABSTRACT The Staudinger reaction, first reported by Hermann Staudinger in 1907 as a ketene–imine [2+2] cycloaddition for the synthesis of β-lactams, has evolved into one of the most versatile transformations in modern organic synthesis. Beyond its classical applications in β-lactam formation and azide reduction to primary amines, the reaction now includes several advanced methodologies with broad applications in medicinal chemistry, chemical biology, and materials science. This review summarizes the evolution of the Staudinger reaction from its classical forms to recent developments, including metal-free microwave-assisted Wolff–Staudinger cascade reactions, continuous-flow multicomponent strategies, and ketene generation through toluenesulfonyl chloride (TsCl)-mediated activation. It also highlights the use of Staudinger-based methodologies, such as Staudinger–aza-Wittig, Ugi–Staudinger, and asymmetric catalytic sequences, for the efficient synthesis of five- and six-membered heterocycles, complex alkaloids, and chiral nitrogen-containing compounds. Particular emphasis is placed on compounds reported between 2020 and 2026, with a comparative evaluation of synthetic methodologies, reaction yields, stereochemical outcomes, and biological activities. The review further discusses the pharmaceutical significance of Staudinger-derived molecules, including β-lactam antibiotics that inhibit penicillin-binding proteins, as well as applications in glycobiology, biomolecular labeling, and cancer research. Collectively, these advances demonstrate the continued importance of the Staudinger reaction as a powerful and adaptable platform for the synthesis of biologically relevant molecules and advanced functional materials. Introduction The Staudinger reaction, also known as the Staudinger synthesis or ketene–imine [2+2] cycloaddition, is named after the German chemist Hermann Staudinger (1881–1965).1 After completing his studies at Karlsruhe, Staudinger carried out pioneering research in Zurich, where he discovered that trivalent phosphorus compounds react with diazo compounds, particularly organic azides, to form phosphazenes. This transformation subsequently became known as the Staudinger reaction.2 In 1905, Staudinger also discovered ketenes 1, highly reactive cumulene intermediates that play a crucial role in cycloaddition chemistry. In recognition of his fundamental contributions to polymer science, he was awarded the Nobel Prize in Chemistry in 1953.2,3 Although the Staudinger reaction was discovered at the beginning of the twentieth century, it received relatively little attention for several decades. Its synthetic importance was fully recognized only after the β-lactam ring was identified in the 1940s as the pharmacophoric core of the antibiotic penicillin, highlighting the significance of the ketene–imine cycloaddition in the synthesis of β-lactam compounds. Another major milestone in the development of the Staudinger reaction was achieved through detailed mechanistic investigations conducted during the 1990s. Computational and experimental studies by Cossío and co-workers demonstrated that the Staudinger [2+2] cycloaddition does not proceed through a concerted pericyclic mechanism. Instead, the reaction follows a stepwise pathway involving the formation of a zwitterionic intermediate, which subsequently undergoes a four-electron conrotatory electrocyclization to afford the corresponding β-lactam product.4 Staudinger ketene–imine [2+2] cycloaddition (β-lactam synthesis) The Staudinger reaction is one of the most fundamental and versatile methods for the synthesis of β-lactam (2-azetidinone) derivatives. These heterocyclic compounds are of considerable importance in both synthetic organic chemistry and pharmacology owing to their broad range of biological activities.5 In 1907, Hermann Staudinger reported the [2+2] cycloaddition between a ketene and an imine (Schiff base), providing an efficient route to nitrogen-containing four-membered β-lactam (2-azetidinone) rings (Scheme 1). This pioneering work was published in Berichte der Deutschen Chemischen Gesellschaft.1 Ketenes (Fig. 1) are typically generated in situ from the corresponding acid chlorides in the presence of a tertiary amine, which acts as a base, facilitating formation of the reactive ketene intermediate required for the cycloaddition reaction.6,7 [2+2] cycloaddition of a substituted ketene and an imine (Schiff base) to make a nitrogen-containing four-membered ring, compound 6 (Staudinger reaction). Reproduced from ref. 4 with permission from ACS, copyright © 2008. General structure of ketene 1 and imine 2. Reproduced from ref. 7 with permission from American Chemical Society (ACS), copyright © 1992. The Staudinger reaction is initiated by nucleophilic attack of an imine 2 on the ketene, forming a zwitterionic intermediate 5. This intermediate subsequently undergoes conrotatory electrocyclic ring closure to afford the corresponding β-lactam product (Scheme 1). When a monosubstituted ketene 3 reacts with an acyclic imine 4, two new stereogenic centers are generated at the C3 and C4 positions of the β-lactam ring, resulting in the formation of either cis, trans, or a mixture of both diastereomeric β-lactam derivatives 6. Consequently, controlling the relative stereochemistry (cis/trans selectivity) represents one of the most important aspects of the Staudinger reaction, as it significantly influences the stereochemical outcome and synthetic utility of the process.6 The β-lactam (2-azetidinone) ring 6 constitutes the principal pharmacophore of β-lactam antibiotics, one of the most widely used classes of antibacterial agents. Owing to the remarkable therapeutic importance of these antibiotics, numerous synthetic strategies have been developed for the efficient preparation of β-lactam derivatives.8 Considerable efforts have been directed toward the development of catalytic methods capable of producing β-lactams 6 with high levels of diastereo- and enantioselectivity. Early studies primarily focused on the use of optically active transition-metal catalysts and chiral auxiliaries; however, at the beginning of the twenty-first century, highly efficient organocatalytic approaches for asymmetric β-lactam synthesis emerged.9 Accordingly, numerous enantioselective variants of the Staudinger reaction have been developed using chiral auxiliaries and asymmetric catalytic systems for the efficient synthesis of β-lactam derivatives.10 The reaction of ketenes 7 or 9 with cyclic imines 8 generates two new stereogenic centers at the C3 and C4 positions of the 2-azetidinone ring 10 and 11, resulting in the formation of both cis- and trans-β-lactam diastereomers 15 and 16, as shown in Scheme 2. Consequently, the diastereoselectivity of the Staudinger reaction plays a pivotal role in determining the stereochemical outcome of the cycloaddition. Several mechanistic pathways have been proposed to explain the formation of these diastereomeric products.11 Because relatively few organic transformations can simultaneously generate two stereogenic centers in a single step, the Staudinger reaction continues to be recognized as one of the most efficient and valuable methods for the stereoselective synthesis of β-lactams 15 and 16, making stereochemical control a major focus of contemporary research.6,10 Pathway for the formation of compounds 15 and 16. Reproduced from ref. 6 with permission from ACS, copyright © 2006. The Staudinger reaction has been extensively employed for the synthesis of a wide variety of structurally diverse β-lactam derivatives. Representative examples include bis-spiro-β-lactams and their derivatives,12 substituted 2-((3S,4S)-2-oxo-1,4-diphenylazetidin-3-yl)-1H-benzo[de]isoquinoline-1,3(2H)-dione 20,13 substituted spirocyclic indeno[1,2-b]quinoxaline β-lactam derivatives 18,14 3-amino β-lactams,15 2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid 19,16 β-lactam-N-(thiazol-2-yl)benzenesulfonamide hybrids,17 tetracyclic dibenzo[b,f][1,4]oxazepine-fused β-lactams 17,18 substituted-5-methylene-12-(1H-tetrazol-5-yl)-6,12-dihydro-5H-quinazolino[3,2-a]quinazoline 21, and substituted 2-azido-2H-pyrano[2,3-b]quinoline derivatives 22. Numerous other β-lactam analogues have also been synthesized using the Staudinger reaction. Representative structures of these compounds are presented in Fig. 2. Chemical structure and IUPAC names of different derivatives of compound 6. Reproduced from ref. 13, 14 and 18–20 with permission from Royal Society of Chemistry (RSC), Arkivoc, Molecules, Springer and ACS, copyright © 2017, 2018, 2021 and 2023. To further highlight the novelty and significance of the present review, Table 1 provides a comparison between previously published reviews on Staudinger chemistry and the current review. Unlike earlier reviews, the present article comprehensively covers advances reported between 2020 and 2026, with particular emphasis on recent synthetic methodologies, mechanistic developments, emerging applications, and future research perspectives. Table 1Comparison of the present review with previously published reviews on Staudinger chemistryPrevious reviewPrimary focusLiterature coveredCoverage of Staudinger chemistryBiological/medicinal applicationsMajor limitationNovelty of the present reviewReferencesPalomo et al. (2004)Asymmetric β-lactam synthesis via Staudinger cycloaddition; chiral building blocks for amino acids and peptidesClassical literature (up to 2004)Enantioselective ketene–imine [2+2] cycloaddition using chiral auxiliaries and catalystsBrief discussion of β-lactam antibioticsFocused exclusively on asymmetric β-lactam synthesis; modern Staudinger methodologies not coveredUpdates the classical perspective by incorporating recent advances (2020–2026), including modern synthetic methodologies, mechanistic developments, and broader applications 21 Cossío et al. (2008)Mechanistic investigation of ketene–imine cycloadditionUp to 2008Detailed mechanistic studies of the zwitterionic pathway and stereochemical aspectsNot discussedLimited to mechanistic understanding with little emphasis on synthetic developments or applicationsIntegrates mechanistic insights with recent synthetic methodologies, catalytic strategies, and pharmaceutical applications 4 Deketelaere et al. (2017)Monocyclic 3-amino-β-lactamsUp to 2016Synthesis of monocyclic 3-amino-β-lactamsAntibacterial significance of amino-β-lactamsRestricted to one β-lactam subclassExpands the scope from a single β-lactam subclass to comprehensive Staudinger-mediated transformations and recent synthetic advances 15 Pedrood et al. (2021)Staudinger–aza-Wittig chemistry for heterocycle synthesis2010–2020Phosphine-mediated aza-Wittig reactions for five- and six-membered heterocyclesNot discussedFocused exclusively on aza-Wittig chemistryPlaces aza-Wittig chemistry within the broader context of contemporary Staudinger chemistry, including complementary transformations and applications 22 Bredael et al. (2025)C4-heteroatom-substituted 3-amino-β-lactams (monobactams)Up to 2024Synthesis and SAR of C4-substituted amino-β-lactamsAntibacterial properties and structure–activity relationshipsRestricted to C4-substituted amino-β-lactams; excludes Staudinger reduction, aza-Wittig chemistry, and modern synthetic methodologiesBroadens the discussion beyond amino-β-lactams by critically evaluating recent advances across diverse Staudinger transformations, synthetic strategies, and applications 23 Kaur et al. (2026)Synthesis and biological applications of C-4 functionalized β-lactams2021–2026Staudinger ketene–imine cycloaddition for C-4 aryl- and heteroaryl-substituted β-lactamsAntibacterial, antifungal, anticancer, antioxidant, anti-inflammatory, antidiabetic, antiviral and enzyme-inhibitory activities supported by SAR studiesLimited exclusively to C-4 functionalized β-lactams; does not discuss Staudinger reduction, Staudinger ligation, aza-Wittig chemistry or emerging synthetic methodologiesExtends beyond C-4 functionalized β-lactams by integrating the full spectrum of recent Staudinger chemistry, mechanistic developments, modern synthetic methodologies, and broader pharmaceutical applications 24 Present reviewComprehensive review of recent advances in Staudinger chemistry, including synthetic methodologies, mechanistic developments, heterocycle synthesis, and pharmaceutical applications2020–2026Comprehensive coverage of classical ketene–imine [2+2] cycloaddition, stereoselective and asymmetric β-lactam synthesis, Staudinger reduction, Staudinger ligation, Staudinger–aza-Wittig chemistry, synthesis of five- and six-membered heterocycles, continuous-flow synthesis, microwave-assisted Wolff–Staudinger cascade reactions, TsCl-mediated ketene generation, multicomponent reactions, catalytic methodologies, and recent mechanistic advancesβ-Lactam antibiotics, chemical biology, glycobiology, biomolecular labeling, cancer research, PET radiotracers, anticoagulants, multidrug-resistance reversal, antimicrobial and antitumor applicationsComprehensively covers the selected literature period (2020–2026)Provides the most comprehensive and up-to-date overview of advances reported between 2020 and 2026 by integrating β-lactam synthesis, Staudinger reduction, Staudinger ligation, Staudinger–aza-Wittig chemistry, heterocycle synthesis, mechanistic developments, continuous-flow and microwave-assisted methodologies, together with biological and pharmaceutical applications and critical comparison of recent synthetic strategiesThis work Comparison of the present review with previously published reviews on Staudinger chemistry Staudinger-azide reduction In 1919, Hermann Staudinger and Jules Meyer reported another important transformation, now known as the Staudinger reduction. This reaction has become one of the most widely used methods for the preparation of primary amines 28 from organic azides and represents a fundamental transformation in organic synthesis and chemical biology.25 In the Staudinger reduction, organic azides are converted into primary amines 28 through a phosphine-mediated reduction, significantly expanding the synthetic utility of organophosphorus chemistry.26 The reaction is initiated by the nucleophilic addition of a tertiary phosphine, most commonly triphenylphosphine (PPh3), to compound 23, leading to the formation of a transient phosphazide intermediate 25 (Scheme 3). Subsequent extrusion of molecular nitrogen (N2) through a four-membered cyclic transition state affords an iminophosphorane intermediate 26, also referred to as an aza-ylide. In the classical Staudinger protocol, trivalent phosphines, particularly compound 24, reduce compound 23 in an aqueous medium via the iminophosphorane intermediate 26.27 Although the formation of triphenylphosphine oxide provides a strong thermodynamic driving force for the reaction, the reduction may proceed slowly when the corresponding iminophosphorane intermediate is kinetically stable.28–30 Synthesis of primary amines by reduction of compound 23 through a phosphine-mediated process. Reproduced from ref. 26 with permission from Elsevier, copyright © 1981. The Staudinger reduction has been widely applied to the synthesis of numerous heterocyclic compounds and their derivatives, including N-heterocyclic carbenes,9 5′-α-iminophosphates,31 4,6-unsubstituted 2-aminodihydropyrimidine-5-carboxylates,32 triazinyl phosphoramidate oligonucleotides,33 and 2H-pyrrolo[3,4-c]quinoline derivatives,34 among many others. In one notable application, azide-functionalized cell-surface glycoconjugates, generated through the metabolic incorporation of synthetic azido sugars, were selectively labeled with a biotinylated phosphine reagent to produce stable cell-surface conjugates. The exceptional chemoselectivity of this reaction has enabled its application in living systems and has provided new opportunities for investigating intracellular biological processes and biomolecular interactions.35 Biological evaluation The β-lactam ring 6 constitutes the structural core of the most clinically important classes of antibiotics, including penicillins, cephalosporins, carbapenems, and monobactams, which remain among the most frequently prescribed antibacterial agents worldwide.21 These antibiotics exert their antibacterial activity by irreversibly acylating the active-site serine residues of penicillin-binding proteins (PBPs), the transpeptidase enzymes responsible for bacterial peptidoglycan cross-linking. Inhibition of these enzymes disrupts bacterial cell-wall biosynthesis, ultimately leading to cell lysis and death. In addition to their antibacterial activity, β-lactam derivatives have been identified as potent inhibitors of viral proteases, human leukocyte elastase, and several other mammalian serine hydrolases, considerably broadening their therapeutic potential. Recent studies have also focused on the development of novel β-lactam frameworks and β-lactamase-resistant analogues to overcome emerging antimicrobial resistance.36 Furthermore, the development of asymmetric and catalytic Staudinger reactions employing chiral auxiliaries, organocatalysts, and transition-metal catalysts has represented a major advance in asymmetric synthesis over the past three decades.6,10 Staudinger reaction is used to provide a synthetic route for diverse medicinal compounds like compounds 29, 30, 31, 32, and 33, which would be further used as an important structural core in the synthesis of various biological compounds like losartan, ezetimibe, clonidine, imiquimod, and vasopressin V1 antagonist and other drugs shown in (Fig. 3). Staudinger reaction as a synthetic route to diverse drug scaffolds, using compound 29, 30, 31, 32 and 33. Reproduced from ref. 37–41 with permission from Elsevier, ACS, Georg Thieme Verlag, and MDPI, copyright © 2012, 2013 and 2018. In cancer research, it has been employed in combination with azide–alkyne click chemistry for the biotinylation and detection of proteins within cancer cells.42 In addition, azide–phosphine conjugation has been utilized for the preparation of homogeneous biotherapeutics and antibody–drug conjugates.43 Phosphoramidate-modified oligonucleotides, including N-(4-carboxybenzenesulfonyl)-phosphoramidate derivatives, have also been functionalized with di- and polyamines to introduce positively charged side chains that may enhance intracellular delivery.44 Moreover, biocatalytic approaches, including the asymmetric reduction of imines 4 by imine reductases and the reductive amination of ketones catalyzed by reductive aminases (RedAms) or amine dehydrogenases, provide efficient routes to chiral amines.45 Owing to the high enantioselectivity of these enzymes, the asymmetric reduction of imines has emerged as a valuable strategy for the synthesis of optically active amine derivatives.46 Compounds like 34–40, prepared through the Staudinger reaction and its mechanistic variants, have found widespread applications in chemical biology and medicinal chemistry and are shown in Table 2. Table 2Structural features and biological activities of selected bioactive compoundsCompound numberCommon nameChemical structureBiological significancePharmacological applicationReference34(+)-Aspidophylline Reverse drug resistance in human cancer cells (e.g., KB nasopharyngeal carcinoma cells)MDR reversal 47, 4835Edoxaban Suppresses thrombin production and platelet activation by inhibiting factor XaAnti-coagulant 49, 50362-[18F]Fluoroethyl azide PET radiotracer/radioligand targeting GABAA receptors in the brain and visualizing its distributionGABAA-receptor radioligand/radiotracer 51 37Combretastatin A-4 Tubulin-binding cytotoxic agent with vascular disrupting effects by binding at the colchicine siteAntitumor 40 38Microcin C Inhibiting aspartyl-tRNA synthetase to drive gut microbial competitive exclusion for targeted antimicrobial therapiesAnti-bacterial 52, 5339Indole-β-lactam hybrid Highly selective anticancer agent by arresting the G2 cell cycle in leukemia and colon cancer cellsAnticancer 54 40Doxorubicin Prodrug Staudinger reaction activates this for tumor-targeted delivery and lessens severe cardiotoxicityAntitumor 55 Structural features and biological activities of selected bioactive compounds The Staudinger reaction remains a highly versatile synthetic platform for the preparation of a broad range of structurally diverse compounds rather than a single class of molecules. Recognizing its continued significance, this review focuses on recent advances in the synthesis of various compounds using Staudinger-based methodologies. Furthermore, it provides a comparative analysis of the reported synthetic approaches, critically evaluates their advantages and limitations, and discusses current challenges, emerging trends, and future perspectives for the application of the Staudinger reaction in modern synthetic and medicinal chemistry. Synthesis by Staudinger reaction The structural diversity of compounds accessible through the Staudinger reaction is remarkable. A wide variety of molecules, including β-lactam derivatives, products obtained via the Staudinger reduction, and numerous heterocyclic compounds, have been successfully synthesized using this transformation and are well documented in the literature. Fig. 4 summarizes representative compounds 41–50 synthesized via the Staudinger reaction between 2000 and 2015, together with their corresponding names and chemical structures. Structure of compounds synthesized via the Staudinger reaction. Reproduced from ref. 56–63 with permission from Beilstein-Institut, Elsevier, Der Pharma Chemica, John Wiley & Sons, Elsevier and Springer, copyright © 2005, 2006, 2009, 2012 and 2013. Synthesis of β-lactam via Staudinger reaction The antibacterial properties of penicillin were first discovered by Alexander Fleming in 1928 during studies involving Staphylococcus aureus. Fleming observed that one of his bacterial cultures had been accidentally contaminated with the blue-green mold Penicillium notatum, and that bacterial growth was inhibited in the area surrounding the mold. Recognizing the significance of this unexpected observation, he isolated the active antibacterial substance, which he named penicillin, and subsequently reported its discovery and potential therapeutic applications.64 However, it was not until 1940 that the first therapeutic studies of compound 60 against streptococcal infections were successfully conducted in mouse models, marking the beginning of the clinical development of β-lactam 51 antibiotics.65 Compound 51, also known as 2-azetidinones or β-lactams, represents an important class of four-membered nitrogen-containing heterocyclic compounds consisting of a cyclic amide ring with a carbonyl group12 Despite structural variations introduced by different substituents, all β-lactam antibiotics share three essential structural features: (i) a four-membered β-lactam ring 51 that is responsible for their characteristic acylation of biological targets; (ii) significant ring strain arising from the bicyclic amide framework, which enhances their chemical reactivity; and (iii) an acidic functional group that is crucial for molecular recognition by the active site of bacterial transpeptidases, also known as PBPs.66 β-Lactam antibiotics constitute one of the most extensively prescribed classes of antimicrobial agents and are available in both oral and parenteral formulations. Their broad-spectrum antibacterial activity, high therapeutic efficacy, and favorable safety profile have established them as the most widely used antibiotics in clinical practice.67,68 In addition to their well-known antibacterial properties, β-lactam derivatives have been reported to exhibit a wide range of biological activities, including HIV-1 protease inhibition,69 antioxidant activity, cholesterol absorption inhibition,70 antifungal and antimalarial effects,71 as well as antitumor activity.72,73 Classes of β-lactam All commercially available β-lactam antibiotics contain a highly reactive β-lactam ring 51, a four-membered cyclic amide characterized by significant ring strain, which is essential for their antibacterial activity (Table 2). Based on the nature of the fused or monocyclic ring system, β-lactam antibiotics are classified into five major structural classes: monobactams 52, penams 53, carbapenems 54, cephems 55, and penems 56, as illustrated in Fig. 5.65 Different classes of compound 51. Reproduced from ref. 84 with permission from Molecules, copyright © 2025. Monobactams 52 are monocyclic β-lactam antibiotics that exhibit high stability toward many β-lactamases. They possess potent antibacterial activity against Gram-negative bacilli but show limited efficacy against Gram-positive bacteria and anaerobic microorganisms. Aztreonam 59 was the first clinically approved member of this class.65 Currently, combinations of compound 59 with other β-lactam antibiotics or diazabicyclooctane-based monocyclic β-lactams are being investigated in preclinical studies for the treatment of infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative pathogens.74,75 Penams 53 are characterized by an azabicyclo[3.2.0]heptane ring system containing a sulfur atom at the C1 position and a carboxylic acid group at the C3 position. Compound 60 (benzylpenicillin or penicillin G), originally isolated from Penicillium chrysogenum, is the prototype and most widely recognized member of this class.64,76 Penems 56 are structural analogues of compound 52, distinguished by the presence of a double bond between the C2 and C3 positions of the fused five-membered ring.77 This class includes clinically important compounds such as faropenem, ritipenem, and sulopenem, and continues to attract considerable research interest in the development of new β-lactam antibiotics.78–80 Cephems 55, represented primarily by the cephalosporins 57, constitute one of the most successful and widely prescribed classes of anti-infective agents. They were developed shortly after the discovery of compound 60 and are generally well tolerated. Structurally, cephems 55, possess a dihydrothiazine ring fused to the β-lactam ring 51, which contributes to their distinctive chemical and biological properties.81–83 Carbapenems 54 are another important class of β-lactam antibiotics and are structurally related to compound 57. Compound 62, the first clinically introduced carbapenem, exhibits broad-spectrum antibacterial activity against Gram-positive bacteria, Gram-negative bacteria, and anaerobic microorganisms. Although carbapenems are resistant to many β-lactamases, compound 62 is susceptible to hydrolysis by renal dehydropeptidase I and is therefore co-administered with the dehydropeptidase inhibitor cilastatin to enhance its therapeutic efficacy.65 β-Lactam antibiotics 51 exert their antibacterial activity by inhibiting PBPs, also known as transpeptidases, which are essential enzymes involved in the biosynthesis of peptidoglycan and the bacterial cell wall.85 Peptidoglycan is a major structural component of the bacterial cell envelope that provides mechanical strength, maintains cell shape, and protects the cell against internal osmotic pressure. PBPs catalyze the cross-linking of peptide side chains between adjacent peptidoglycan strands within the periplasmic space, thereby forming the rigid mesh-like structure of the bacterial cell wall. Owing to the structural similarity of the β-lactam ring to the terminal d-alanyl–d-alanine (d-Ala–d-Ala) moiety of N-acetylmuramic acid (NAM) peptidoglycan precursors, PBPs recognize β-lactam antibiotics as their natural substrates. Consequently, the β-lactam ring covalently acylates the active-site serine residue of PBPs, resulting in irreversible inhibition of their transpeptidase activity. This inhibition prevents peptidoglycan cross-linking, leading to the accumulation of cell wall precursor molecules and disruption of cell wall biosynthesis. The resulting imbalance activates bacterial autolytic enzymes, ultimately causing cell wall degradation, osmotic instability, and bacterial cell lysis86,87 (Fig. 6). Various antibiotics containing compound 51. Reproduced from ref. 88–90, with permission from Molecules and ACS, copyright © 2020, 2023 and 2025. β-Lactam derivatives 51 are predominantly synthesized through the Staudinger [2+2] ketene–imine cycloaddition, as illustrated in Scheme 1. In most synthetic protocols, the ketene intermediate 1 is generated in situ from its corresponding precursors because of its high reactivity and limited stability. This versatile methodology enables the synthesis of a wide range of β-lactam derivatives through the use of different ketene 1 precursors, imines 2, catalysts, and reaction conditions, providing efficient access to structurally diverse and stereochemically defined products. The following sections summarize the recent advances in the synthesis of compound 51via the Staudinger reaction, with particular emphasis on studies reported between 2020 and 2026. cis or trans-Diastereoselectivity synthesis of 1,3-diaryl-spiro[azetidine-2,3-indoline]-2,4-diones Although the synthesis of spiro-β-lactams via the Staudinger reaction has been reported previously, the influence of reaction conditions on diastereoselectivity has received limited attention. In the present study, an efficient method was developed for the synthesis of compounds 69 and 70 through the Staudinger reaction using in situ ketene generation from substituted phenylacetic acids, oxalyl chloride, and N,N-diisopropylethylamine (DIPEA). Unlike conventional Staudinger protocols, the modified procedure enables reversal of the diastereoselectivity, allowing selective formation of either compound 69 or 70 under appropriate reaction conditions. The synthesis commenced with the preparation of the corresponding Schiff base. Compound 63 was added to a boiling solution of isatin 64 in 25 mL of absolute ethanol containing a catalytic amount of acetic acid. The reaction mixture was refluxed for 3 h, and the progress of the reaction was monitored by thin-layer chromatography (TLC). After completion, the mixture was cooled to room temperature and filtered under reduced pressure. The resulting precipitate was washed with 25 mL of cold ethanol, dried, and isolated as compound 65 (Scheme 4). Synthesis of compound 65. Reproduced from ref. 91 with permission from RSC, copyright © 2020. In the second step, the diastereomeric spirooxindole β-lactam derivatives were synthesized via the Staudinger cycloaddition. A solution of compound 66 in anhydrous tetrahydrofuran (THF) was prepared, after which compound 67 was added dropwise in the presence of 1–2 drops of anhydrous dimethylformamide (DMF) as a catalyst. The reaction mixture was refluxed for approximately 2 h, and the solvent was subsequently removed under reduced pressure to afford a dark yellow oily intermediate 68 for further transformation (Scheme 5). Synthesis of compound 68. Reproduced from ref. 91 with permission from RSC, copyright © 2020. Subsequently, compound 68 was added to a boiling solution of the corresponding Schiff base and triethylamine (Et3N) in anhydrous DMF. The reaction mixture was refluxed for 7–9 h and then allowed to cool to room temperature before being poured into cold water. The solvent was removed under reduced pressure, and the resulting residue was purified by silica gel column chromatography using a petroleum ether/ethyl acetate (65 : 35) eluent. Final recrystallization from diethyl ether afforded the desired β-lactam products as white solids, yielding both the major and minor diastereomeric products (Schemes 6 & 7). The protocol employing pre-isolated acid chlorides (Scheme 6) provided moderate yields (44–64%), whereas the in situ activation strategy using oxalyl chloride/DIPEA (Scheme 7) afforded yields of up to 84%. Notably, the two approaches exhibited distinct stereochemical preferences for the same substrates: the former predominantly produced the cis-diastereomer 70 (approximately 1 : 2 diastereomeric ratio), while the latter favored formation of the trans-isomer 69. In addition, the methodology demonstrated broad substrate applicability, successfully furnishing 21 derivatives of compound 65 and two derivatives of compound 66, while also identifying substrates that failed under the optimized conditions. The in situ protocol further simplified the synthesis by eliminating the need to isolate acid chloride intermediates. Overall, these findings highlight a trade-off between the reproducible performance of the pre-isolated acid chloride route and the greater operational simplicity, higher attainable yields, and improved stereochemical control offered by the in situ activation strategy.91 Staudinger synthesis of compound 69 minor and 70 major using compound 68. Reproduced from ref. 91 with permission from RSC, copyright © 2020. Staudinger synthesis of compound 69 minor and 70 major without using the prepared compound 68. Reproduced from ref. 91 with permission from RSC, copyright © 2020. cis-Diastereoselective synthesis of spirooxindolo-β-lactams using TsCl as activating co-reagent Molecularly targeted cancer therapy using small-molecule inhibitors (SMIs) has emerged as a promising alternative to conventional chemotherapy because of its high selectivity toward tumor cells and reduced toxicity to normal tissues. Among the numerous molecular targets implicated in cancer, murine double minute 2 (MDM2) has attracted considerable attention. The spiro-oxindole framework has been recognized as a privileged scaffold for the development of MDM2 inhibitors, as its rigid spirocyclic architecture provides conformational stability, facilitates structural diversification, and enables favorable binding of compounds 69 and 70 within the MDM2 active site. However, conventional Staudinger syntheses employing ketenes generated from acid chlorides predominantly afforded the undesired compound 69 as the major diastereomer. Moreover, the high reactivity and instability of compound 67 complicated the synthetic process, although one-pot procedures improved cis-selectivity. To address these limitations, Vadim E. Filatov and co-workers introduced tosyl chloride (TsCl) 76 as a milder and more practical activating reagent 75 for the in situ generation of compound 78 during the Staudinger synthesis of compounds 86 and 87. In this approach, TsCl served as the activating co-reagent in a ketene–imine [2+2] cycloaddition, enabling the efficient one-pot synthesis of compound 73 from isatin-derived Schiff bases and substituted phenylacetic acids (Scheme 8). Except for the substrate derived from 4-methoxyphenylacetic acid, the reaction afforded β-lactam products with high cis-selectivity without requiring rigorously anhydrous conditions or unstable reagents. The synthesis began with the preparation of compound 71 through condensation of isatin 64 with various aromatic amines in the presence of glacial acetic acid as a catalyst. Depending on the substrate, two synthetic procedures were employed. Diastereoselective one-pot synthesis of compound 73 from compounds 71, 72, and TsCl. Reproduced from ref. 92 with permission from ACS, copyright © 2021. In the conventional method, compound 71 was prepared by refluxing isatin 64 with the appropriate aromatic amine in absolute ethanol for 3 h. Alternatively, a microwave-assisted protocol was performed in methanol at 70 °C for 15 min, providing a rapid and efficient route to the corresponding Schiff bases (Scheme 4). For the Staudinger cycloaddition, compound 72 was first treated with TsCl and DIPEA in dry o-xylene at 100 °C for 1.5 h, generating the corresponding mixed anhydride intermediate. Subsequent elimination produced the highly reactive ketene 78in situ. After cooling the reaction mixture to room temperature, compound 71 and an additional equivalent of DIPEA were added to initiate the ketene–imine [2+2] cycloaddition (Scheme 9). Proposed mechanism of activation by TsCl. Reproduced from ref. 92 with permission from ACS, copyright © 2021. The reaction was monitored by TLC, and upon completion, the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography using a hexane/ethyl acetate eluent, followed by recrystallization from diethyl ether, affording compounds 86 and 87 as white crystalline solids. For substrates exhibiting limited solubility in o-xylene, such as 4-hydroxyphenylisatin imines, 1,4-dioxane was employed as an alternative reaction solvent (Scheme 10). Possible mechanism for the synthesis of compounds 86 and 87. Reproduced from ref. 92 with permission from ACS, copyright © 2021. The reaction conditions were found to have a pronounced influence on the diastereoselectivity of the Staudinger cycloaddition. Low temperatures and low-polarity solvents, such as o-xylene, favored the formation of compound 86, whereas elevated temperatures and highly polar solvents, including 1,4-dioxane, promoted the preferential formation of compound 87. This solvent-dependent stereochemical outcome was attributed to the stabilization of Zwitter ion intermediates. Polar solvents stabilize the EZ-type zwitterionic intermediate 85, suppressing its direct cyclization to compound 86 and allowing isomerization to the ZZ-type zwitterionic intermediate 82, which subsequently cyclizes to afford compound 87. An exception to the general diastereoselectivity trend was observed for 4-methoxyphenylacetic acid, where compound 87 remained the predominant product even under ambient reaction conditions. Efficiency varied from 20% to 69% for the cis-isomers and only from 3% to 26% for the trans-isomers. Furthermore, selectivity tended to decline with increasing solvent polarity or temperature. For the majority of substrates, the cis-diastereomer was the predominant result; however, 4-OMe-substituted acids showed a preference for the trans-isomer. The methodology was applied to seven derivatives of compound 71 and six derivatives of compound 72, demonstrating moderate substrate scope. However, the protocol relied on TsCl/DIPEA activation and was limited to small-scale reactions (1–2 mmol), which may restrict its preparative scalability.92 Dispirooxindole-β-lactam synthesis Bacterial infections and cancer continue to represent major global health challenges, driving the development of new targeted therapeutic strategies. Among these, small-molecule therapeutics have attracted considerable interest because of their oral bioavailability, high stability under physiological conditions, and ease of structural modification and functionalization. β-Lactam 51 derivatives constitute one of the most important privileged scaffolds in medicinal chemistry. The compounds described in this study combine the β-lactam ring with a rigid three-dimensional spirocyclic framework, a structural feature that enhances molecular rigidity while providing multiple opportunities for functionalization. Recently, a straightforward synthetic approach to novel diarylspiro[azacyclobutane-2,3-indoline]-2,4-diones was reported. Preliminary in vitro biological evaluation and molecular docking studies demonstrated favorable affinity toward the target protein, and the compound 92 framework was synthesized successfully for the first time. The synthesis of compounds 86, 87, and 92 was accomplished through a one-pot Staudinger ketene–imine [2+2] cycloaddition, employing compound 90 as the ketene precursor. In this methodology, compound 90 was reacted with isatin-derived imines, while TsCl served as the activating co-reagent to generate the ketene intermediate in situ from the corresponding keto acid. The resulting β-lactam derivatives 86, 87, and 92 were subsequently evaluated for their binding affinity toward MDM2. The synthesis of compound 90 commenced with the reaction of compound 89 and compound 88 (Scheme 11). Compound 89 (4 mmol) was dissolved in 10 mL of anhydrous acetonitrile in a round-bottom flask at room temperature, and the solution was purged with dry argon for 10 min. Subsequently, compound 88 (8 mmol) was added, and the reaction mixture was further purged with dry argon for 30 min before being stirred at room temperature for 48 h. After removal of the solvent under reduced pressure, a beige-to-brown solid was obtained. This crude product was dissolved in 30 mL of dichloromethane and washed twice with 10 mL portions of 10% hydrochloric acid. The organic Na2SO4 dried over anhydrous Na2SO4 and concentrated under reduced pressure to afford compound 90 as a white-to-beige solid. Synthesis of compound 90 through homoconjugate addition of compound 89. Reproduced from ref. 93 with permission from Molecules, copyright © 2022. Compound 92 was synthesized from compound 90 following the general procedure outlined in Scheme 12, involving TsCl/DIPEA-mediated activation in anhydrous o-xylene, followed by reaction with compound 91 and purification by column chromatography. The isolated yields of intermediate 90 ranged from 65–87%, whereas the final spiro-β-lactams 92 were obtained in 35–62% yield, accompanied by 2–7% by-product formation. Notably, the transformation proceeded in a diastereospecific manner, exclusively affording the trans-isomer of 92. The methodology was successfully applied to two derivatives of compound 91 and five derivatives of compound 88, demonstrating moderate substrate scope; however, the reaction was limited to a 1–1.5 mmol scale, restricting its preparative applicability. Although incorporation of the spiro linkage enhances molecular rigidity and structural complexity, the additional cyclization step increases the overall synthetic sequence, thereby reducing atom economy and diminishing the overall greenness of the protocol.93 Synthesis of compound 92via Staudinger ketene–imine cycloaddition using compound 90 as a source of ketene. Reproduced from ref. 93 with permission from Molecules, copyright © 2022. Stereoselective monocyclic cis-bis-β-lactams synthesis including a 1,3,4-thiadiazole 2,5-dithiol constituent Vedeshwar et al. reported an efficient Staudinger [2+2] ketene–imine cycloaddition strategy for the synthesis of compound 99 incorporating a compound 94 framework. This transformation employed acyl chlorides and a series of aromatic imines as the key reaction partners. Owing to their broad spectrum of biological activities, β-lactams have attracted considerable attention as privileged structural motifs in medicinal chemistry and have been widely utilized in the development of biologically active molecules and therapeutic agents. According to the authors, this study represents the first reported synthesis of compound 99 containing a compound 94 moiety. The antibacterial potential of the synthesized derivatives was evaluated against the Gram-positive bacterial strains Bacillus anthracis, Clostridium perfringens, and Staphylococcus aureus using the minimum inhibitory concentration (MIC) assay. The synthetic route commenced with the preparation of compound 95 by reacting compounds 93 and 94 in acetonitrile in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) as the base (Scheme 13). The crude product was purified by recrystallization using dry dichloromethane and dry hexane. Subsequently, compound 95 was condensed with compound 96 in dry ethanol under reflux in the presence of p-toluenesulfonic acid (PTSA) as the acid catalyst and anhydrous magnesium sulfate (MgSO4) as the dehydrating agent to afford a series of imine intermediates 97 (Scheme 14). In the final step, 2-phenoxyacetyl chloride 98 and Et3N were employed to generate the corresponding ketene in situ in dry dichloromethane (DCM). The resulting ketene underwent Staudinger [2+2] cycloaddition with the prepared imines to furnish the desired compound 99 (Scheme 15). Optimization of the reaction conditions improved the isolated yields from 18% to 88%, with optimized conditions consistently affording approximately 78% yield. The reaction proceeded with high cis-diastereoselectivity (J3,4 = 5.3–5.6 Hz). The methodology was applied to six derivatives of 96 and two derivatives of 98. Although limited to a 0.5–0.6 mmol scale, the protocol eliminated the need for column chromatography, simplifying product isolation.94 Synthesis of compound 95 from compound 93 and 94. Reproduced from ref. 94 with permission from John Wiley & Sons, copyright © 2023. Formation of compound 97 from compound 95 and 96. Reproduced from ref. 94 with permission from John Wiley & Sons, copyright © 2023. Synthesis of compound 99 from compound 97 and 98. Reproduced from ref. 94 with permission from John Wiley & Sons, copyright © 2023. Synthesis of spiro bis-β-lactams via a metal-free microwave-assisted Wolff and Staudinger reaction Krivovicheva et al. developed a metal-free microwave-assisted Wolff/Staudinger cascade reaction for the efficient synthesis of compound 103 from compounds 100 and 102. In this methodology, compound 100 initially undergoes a Wolff rearrangement to generate the highly reactive ketene intermediate 101, which subsequently participates in a Staudinger [2+2] ketene–imine cycloaddition with the corresponding Schiff base 102 to afford the desired β-lactam derivative (Scheme 16). The reaction was initially performed under conventional heating at 200 °C for 3 h, providing compound 103 in 72% yield. Reaction optimization using microwave irradiation at the same temperature significantly reduced the reaction time to 1 h while minimizing tar formation and improving the overall efficiency of the process. Thermal decomposition of compound 100 with compound 102 to compound 103. Reproduced from ref. 95 with permission from ACS, copyright © 2024. Experimentally, compound 104 and compound 105 were dissolved in 1 mL of dry chlorobenzene in a sealed reaction vessel and heated under microwave irradiation at 200 °C for 1 hour (Scheme 17). During the reaction, compound 104 underwent Wolff rearrangement to generate the corresponding acyl ketene 101, which subsequently reacted with compound 102 through a Staudinger [2+2] cycloaddition to produce compound 103. The reaction exhibited excellent stereochemical control, with most of the products 106 being obtained as single diastereomers, in which the carbonyl group of the first β-lactam ring and the R3 substituent of the imine were positioned on the same face of the molecule. With efficiency ranging from 20% to 96%, this technique showed a wide substrate scope for derivatives of 100/104 and 102/105. Stereoselectivity was consistently high, usually favoring the cis-isomer with ratios surpassing 95 : 5, but 5-monosubstituted diazotetramic acids generated an additional stereogenic center, affording the corresponding products with diastereomeric ratios of up to 85 : 15. From the standpoint of green chemistry, this metal-free, microwave-assisted Wolff rearrangement method is superior because it does not require activation by reagents like TsCl or acyl chlorides, only produces nitrogen gas as a byproduct, shortens the reaction time from three hours to one hour, and only needs recrystallization for purification.95 Synthesis of compound 106 by microwave irradiation. Reproduced from ref. 95 with permission from ACS, copyright © 2024. Novel bis-spiro-β-lactams synthesis from some quinolinones Over the past few decades, significant effort has been devoted to the discovery and development of novel β-lactams with enhanced activity. However, efforts directed toward the development of spiro-β-lactams have been limited. Staudinger cycloaddition was used to produce compound 113 by Fadhil and colleagues using quinolinone. The artificial sequence was made in four steps. The initial step involved cyclizing compound 107 using ethanol with compound 108 in concentrated sulfuric acid under reflux conditions for 7 hours to produce compound 109. Then, 6 hours of refluxing this compound with compound 110 in benzene with acetic acid were done to produce compound 111. Compound 111 was recrystallized and reacted with compound 112 in toluene with Et3N at 25 °C for 7 hours to give the desired compound 113 in 69–77% yield. The Staudinger cycloaddition was conducted by adding compound 112 (0.002 mol) to a mixture of compound 111 (0.001 mol) and Et3N (0.5 mL) in toluene (40 mL) stirred until the reaction was finished (7 hours), then filtered and recrystallized in ethyl acetate (Scheme 18). The reaction's substrate scope was restricted to 3 derivatives of compound 110. From a green chemistry point of view, purification was only restricted to recrystallization of compound.12 Synthesis of compound 113 from compound 111 and 112via Staudinger reaction. Reproduced from ref. 12 with permission from Springer, copyright © 2024. Expedited access to β-lactams via telescoped three-component reaction in flow The Staudinger reaction, which involves the thermal cycloaddition of imines and ketenes, is frequently used to create β-lactams. Its activity has historically been limited by its inability to form a complex with compound aldehyde, ketene, and amine. In 2024, Minuto and coworkers performed a three-step Staudinger reaction in series for the first time. This reaction takes advantage of the photochemical Wolff rearrangement of diazoketones and in situ generation of imine. Imines were made by dehydrating compound 118 and 119 in a packed bed reactor with basic alumina serving as the solvent. The dehydration rates of the telescoped flow approach are rapid (tResca. 3 minutes), combined with effective Wolff rearrangement using LEDs (420 nm) to deliver the required compound 122 in less than 30 minutes, which is in line with batch processing times of several days. Ketenes were created in situ via the Wolff photochemical reaction of diazoketones. The study has shown that this method is feasible when visible (blue) light is used in place of UV light, with encouraging selectivity and efficiency outcomes. In order to facilitate quick and effective incorporation into compound 120, they suggested creating a continuous flow channel for the Staudinger multicomponent reaction. An Omnifit glass column (10 cm tall, 6.6 mm inner diameter) was filled with dry Al2O3 (grade I) and sand (ca.). Flow reactors use smaller molds that provide better temperature and pressure control than other batch methods, resulting in micro-mixing that can be improved by using static mixers. Increasing the flow rate and frequency leads to better heat dissipation. (1 : 2 by weight). A Vapourtec E-Series flow reactor with peristaltic pumps was installed in the column. Compound 114, 115, and 116 solutions in dichloromethane (0.1 M) were prepared and injected from a packed bed at a flow rate of 400 µL min−1; a photo-module with high-intensity LEDs (rt, 60 W) was used (Scheme 19). Following purification by flash chromatography, the reaction product was verified. Compound 120 was prepared in accordance with a documented procedure, and the initial reaction was dissolved in DCM (0.04 M) along with compound 121 before being subjected to a photochemical flow module that had 450 nm LEDs. When combined with high-intensity irradiation, increasing the concentration of the substrate solution was found to be advantageous. Continuous flow approach for the Staudinger MCR to synthesize compound 117. Reproduced from ref. 96 with permission from Springer, copyright © 2024. The two components of the complex system are finally combined. A Vapourtec flow reactor's peristaltic pump was used to dissolve compounds 114, 115 and 116 in DCM (molar ratio 1.2 : 1 : 1.1). The mixture went through a column of packed beds (tResca. 3 minutes), producing a compound 120 intermediate that was then mixed with the photo-module's in situ synthesis (Scheme 20). The system was maintained at room temperature, and a second pump operating in reverse mode served as a 1 bar back-pressure regulator. Fortunately, a library of β-lactams that had previously been identified as single compound 122 could be created thanks to this method's high sensitivity, as discussed (Scheme 21). Although this approach works for aryl, heteroaryl, and cyclohexyl derivatives of compounds 114, 115, and 116, aliphatic aldehydes did not react, but it combines a two-component reaction (44–100% efficiency) with a three-component flow reaction stage (20–86% yield). For the majority of substrates, stereoselectivity was strong, producing a single trans-isomer. The procedure was shown to be feasible on a gram scale (4 mmol, 83% yield). Water and nitrogen gas were the sole environmental byproducts, and the space-time yield was 43.5.96 Flow synthesis of compound 120 using a packed column reactor. Reproduced from ref. 96 with permission from Springer, copyright © 2024. Staudinger reaction between compound 121 and 120 to produce compound 122. Reproduced from ref. 96 with permission from Springer, copyright © 2024. Another approach to β-lactam synthesis via continuous flow chemistry Even though β-lactams are extremely essential chemicals, batch processing has been used nearly entirely in their manufacture. Nevertheless, low stereoselectivity, the instability of enolizable imines, and the creation of complicated reaction mixtures as a result of the polymerization of extremely reactive ketene intermediates are problems with batch techniques. In this regard, microreactor-based continuous-flow chemistry has drawn interest as a potential substitute. Flow chemistry is a desirable platform for increasing yields, selectivity, and safety because of its benefits, which include greatly improved mass and heat transfer, accurate temperature control, and the capacity to handle reactive intermediates directly within the system. The synthesis of compound 126 utilizing this continuous-flow method has been described by Deketelaere and co-authors. A model reaction using compound 123 and 125 was chosen in order to assess initial parameters and optimize conditions. This model reaction was first carried out using a batch process to establish baseline data. Compound 118 was refluxed with isopropylamine (1 equivalent) and magnesium sulfate (2 equivalents) in DCM for two hours to produce compound 123 (96% yield). Acetoxyacetyl chloride 125 (1.1 equivalents) was then added dropwise after compound 123 and Et3N (3 equivalents) were dissolved in anhydrous DCM. The target compound 124 was produced exclusively as the cis-isomer and separated in 93% yield by recrystallization from ethanol after the reaction mixture was stirred overnight at room temperature (Scheme 22). Batch process for the model reaction of the Staudinger synthesis of compound 124. Reproduced from ref. 97 with permission from Springer, copyright © 2025. The following general configuration was used to transform the batch method into a continuous flow process: a polytetrafluoroethylene (PTFE) tube reactor was coupled to two syringe pumps via a T-mixer. Compound 123 and the chosen base were provided by one pump, and the compound 125 solution was delivered by the other. The reactor was submerged in an oil bath that was regulated to a specific temperature. The system was given three times the residence time to equilibrate before product collection started. A model β-lactam system was used to do a thorough screening of reaction parameters (Scheme 23). Basic reactor set-up used for Staudinger synthesis of compound 126 by flow chemistry. Reproduced from ref. 97 with permission from Springer, copyright © 2025. Triethylamine (Et3N), DIPEA, N-methyl-2-pyrrolidone (NMP), tetrabutylammonium (TBA), 2,6-lutidine, 2,4,6-collidine, 1,8-diazabicycloundec-7-ene (DBU), 4-dimethylaminopyridine (DMAP), proton sponge, (tert-butylimino)tris(pyrrolidino)phosphorane (BTPP), and 1,4-diazabicyclooctane (DABCO) were evaluated as bases, while N-methyl-2-pyrrolidone (NMP) was examined as the reaction medium. NMP shifted the diastereoselectivity toward the trans-isomer, whereas DIPEA and tributylamine favored the formation of the cis-isomer. Reactor blockage due to hydrochloride salt precipitation was observed with Et3N and 2,6-lutidine. Among the solvents examined (THF, ethyl acetate, acetonitrile, dichloromethane, and toluene), acetonitrile provided the best conversion and diastereoselectivity without reactor clogging. Optimization of the reaction temperature (room temperature – 100 °C) and residence time (15–60 min) identified 50 °C and a 15 min residence time as the optimal conditions for achieving high conversion and cis-selectivity. The methodology was applied to four derivatives of 123 and three derivatives of 125, achieving up to 92% cis-selectivity and a space-time yield of 1706 g L−1 h−1 under continuous-flow conditions, highlighting its excellent scalability.97 Design and synthesis of β-lactams as serine β-lactamase enzyme inhibitor To address the growing challenge of Staphylococcus aureus drug resistance, Salazar et al. (2026) designed, synthesized, and evaluated compounds 130, 131, and 132 as potential serine β-lactamase inhibitors. A clavulanic acid-inspired chemical library was constructed in which compound 127 bearing different substituents (H, OCH3, and NO2) was employed to investigate the influence of electronic effects on binding affinity and stereochemical outcome. This approach involved substituent-controlled stereoselectivity; electron-donating groups produced the cis-isomer more frequently, whereas electron-withdrawing groups produced the trans-isomer. The synthetic route began with the preparation of compound 128 by condensing equimolar amounts of compound 127 with compound 118 in ethanol under acidic conditions using HCl as the catalyst. After refluxing for 12 h, the reaction mixture was purified by sublimation followed by recrystallization to afford the corresponding imine intermediates. These imines subsequently served as electrophilic partners in the Staudinger [2+2] ketene–imine cycloaddition. For the synthesis of compounds 130, 131, and 132, each compound 128 derivative (2 g) was dissolved in anhydrous dichloromethane under a nitrogen atmosphere and cooled to −78 °C. A solution of compound 129, the ketene precursor, was added together with Et3N, which acted both as the base for in situ ketene generation and as an acid scavenger for the hydrochloric acid produced during the reaction. The reaction mixture was maintained at −78 °C for 2 h, followed by stirring at room temperature for 48 h. After completion, the mixture was washed with 10% aqueous sodium bicarbonate, and the crude products were purified by flash column chromatography using hexane/ethyl acetate (9 : 1) as the eluent. The target compounds 130, 131, and 132 were isolated in 22–50% yield (Scheme 24). The methodology was evaluated using three derivatives of 127 and was demonstrated only on a 2 g reaction scale, limiting assessment of its broader scalability.98 Preparation of compound 130, 131 and 132 (serine β-lactamase inhibitor) from compound 128, by Staudinger cycloaddition [2+2]. Reproduced from ref. 98 with permission from Elsevier, copyright © 2026. Synthesis of azaindole-β-lactam A synthetic method for joining an azaindole heterocycle with a β-lactam ring was disclosed by Bartolacci and co-authors. To ensure that the Staudinger reaction with compound 133 proceeds smoothly, this method uses a new approach involving the protective group at the N1 position. The difficulty was in making compound 133 stable and soluble, as well as protecting its endocyclic nitrogen (N1), before transforming it into an imine and combining it with a ketene to create the β-lactam through a Staudinger [2+2] cycloaddition. After analyzing many protecting groups (tetrahydropyranyl (THP), tert-butyloxycarbonyl (BOC), tosyl, and dimethoxymethyl (DMM)), the research team determined that DMM was the best option. Unlike THP and BOC, which caused reaction failures or the loss of the protective group, DMM protection offers a number of benefits, including high-yield, clean reactions, easy deprotection using trifluoroacetic acid (TFA), and excellent stability throughout future steps. By selecting a ketene precursor, the scientists were able to manipulate the stereochemistry (cis or trans) and create a small library of compound 138. First, formylation was used to add a formyl group to the C3 position of unsubstituted azaindole. The resultant compound 134 was condensed with a primary amine to create a compound 135 intermediate after being protected. This compound 135 then underwent a Staudinger [2+2] cycloaddition reaction using a ketene that was produced in situ from compound 136 and a base in order to directly create a compound 137 scaffold. The choice of compound 136 could regulate the stereochemistry of the resultant lactam: products with cis configuration were produced by alkoxy- or aryloxyacetyl chlorides, while products with trans configuration were produced by aryl- or alkylacetyl chlorides. Trifluoroacetic acid was used to cleave the protecting group after compound 137 formed, releasing the nitrogen on the azaindole ring and producing the target compound 138 with high diastereomeric purity and generally good yields (Scheme 25). With efficiency of 32–83% for the Staudinger-type reaction and 50% for the solid-phase approach, this technique exhibits extensive substrate tolerance for both the ketene and amine coupling partners. Simultaneously, the authors showed that solid-phase resin could also undergo this synthetic sequence, which includes imine production, ketene creation, and Staudinger cyclization.99 Synthesis of compound 138 by using new protecting group strategies. Reproduced from ref. 99 with permission from Elsevier, copyright © 2026. To facilitate comparison of recent advances in Staudinger chemistry, Table 3 summarizes the major methodologies reported between 2020 and 2026, highlighting their representative substrates and products, reaction efficiency, stereochemical outcomes, catalyst/reagent systems, scalability, sustainability, and key advantages and limitations. Table 3Comparative analysis of recent Staudinger methodologies (2020–2026): substrates, products, efficiency, stereochemical outcomes, catalyst/reagent systems, scalability, sustainability, advantages, and limitationsSectionMethodologyRepresentative reactants → productsEfficiency (% yield)Stereochemical outcomeCatalyst/reagent & key conditionsMajor advantagesMajor limitationsScalability/green aspectsReferencesβ-Lactam synthesisAcyl chloride vs. in situ oxalyl chloride activation69–7044–84%Acyl chloride: cis-major; oxalyl chloride: trans-majorAcyl chloride/Et3N or oxalyl chloride/DIPEATunable diastereoselectivity; avoids acid chloride isolationMoisture-sensitive intermediates; long reaction time for acyl chloride route In situ protocol simplifies synthesis 91 β-Lactam synthesisTsCl-mediated one-pot spirooxindolo-β-lactam synthesis86/87 cis: 20–69%; trans: 3–26%Predominantly cisTsCl/DIPEAOne-pot process; avoids unstable ketenesSelectivity depends on substituent, temperature, and solventNo isolation of acid chloride 92 β-Lactam synthesisTsCl-mediated dispirooxindole β-lactam synthesis9235–62% trans-SelectiveTsCl/DIPEAFirst dispiro scaffold; rigid frameworkLong reaction timeNot evaluated 93 β-Lactam synthesisMonocyclic cis-bis-β-lactam synthesis9978–88% cis Acyl chloride/Et3NFirst cis-bis-β-lactam; chromatography-free purificationMulti-step synthesisSimple purification 94 β-Lactam synthesisMetal-free microwave Wolff–Staudinger cascade10620–96%Highly cis-selectiveMicrowave heatingRapid; metal-free; broad scopeRequires 200 °C4× scale-up; N2 only by-product 95 β-Lactam synthesisQuinolinone-derived bis-spiro β-lactams111–11369–77%Not emphasizedPhenoxyacetyl chloride/Et3NMild cycloaddition conditionsNarrow substrate scopeRecrystallization only 12 β-Lactam synthesisTelescoped three-component continuous-flow synthesis114–12220–100%Single trans-isomerPhotochemical Wolff rearrangementFast; safe; no isolation of intermediatesSpecialized flow equipmentGram-scale; only N2 and H2O generated 96 β-Lactam synthesisFlow reactor optimization126Up to 92%Base-controlled cis/transPTFE flow reactorExcellent heat/mass transferRe-optimization requiredHigh productivity 97 β-Lactam synthesisSerine β-lactamase inhibitors130–13222–50%EDG → cis; EWG → transEt3NPotent inhibitor identifiedModerate yields; cryogenic conditionsNot reported 98 β-Lactam synthesisDMM-protected azaindole β-lactams133–13832–83%Ketene-controlledDMM protection/Et3NEffective N-protection strategyVariable solid-phase yieldsNot evaluated 99 Acyl phosphoramidatesModified Staudinger synthesis38Up to 88%Diastereomeric phosphorus centerTMSClMild; scalable; first synthetic routeStoichiometric activator10 mmol scale 52 Heterocycle synthesisUgi/Staudinger/aza-Wittig pyrazinones17483%, 75% stepwiseKeto/enol equilibriumPPh3One-pot multicomponent synthesisStoichiometric phosphineMetal-free 100 Heterocycle synthesisPasserini/Staudinger/aza-Wittig dihydroquinazolines18284%Not applicablePPh3/K2CO3Mild and modular synthesisStrong bases unsuitableMetal-free 101 Staudinger reductionPhosphinoarenesulfonamide-mediated reduction18978–96%Retains stereochemistryPhosphinoarenesulfonamideWater-free; excellent yieldsStoichiometric reagentDemonstrated at 5 mmol 27 Aza-WittigCatalytic asymmetric quaternary oxindoles191/19281–92%; up to 97% eeHighly enantioselectiveChiral phosphine/Ir catalystCatalytic; excellent enantioselectivityUses Ir catalyst and silaneGram-scale; catalyst recyclable 102 Heterocycle synthesisQuinazolinoquinazolines2183% E-SelectiveAgNO3 catalystBroad scopePrecious metal catalystGram-scale 20 Pharmaceutical intermediateEdoxaban intermediate20262–65%High diastereoselectivityDPPA/DIAD/PPh3Safer than NaN3 routeStoichiometric reagents20 g scale 49 Heterocycle synthesisLuminescent indoloquinazolinones21360–92%Not applicableI2/DMSOMetal-freeLimited substrate scopeMetal-free sequence 103 P(v) heterocyclesStaudinger annulation226/227Up to 93%Not applicableTMS additiveBench-stable P(v) heterocyclesSeveral solvents screenedGram-scale 104 Mechanistic studiesStaudinger biradicaloid intermediate23740%Structural characterizationNo catalystFirst isolated intermediateNarrow substrate scopeFundamental study 105 Heterocycle synthesisDiamido N-heterocyclic imines24261%Not applicableMe3SiN3Novel NHC-derived iminesSmall-scale onlyMetal-free 106 BioconjugationTriazinyl phosphoramidate oligonucleotides24840–95%Not applicableAzidotriazinesModular oligonucleotide modificationCustom azides requiredSolid-phase compatible 33 Total synthesisBIBOP-catalyzed asymmetric Staudinger/aza-Wittig253/254Key step 45%AsymmetricBIBOP catalystCatalytic phosphorus cycleModerate yieldReduces phosphine oxide waste 47 Comparative analysis of recent Staudinger methodologies (2020–2026): substrates, products, efficiency, stereochemical outcomes, catalyst/reagent systems, scalability, sustainability, advantages, and limitations Synthesis of 5- and 6-membered heterocycles via Staudinger reaction Heterocyclic compounds are cyclic organic molecules containing one or more heteroatoms within the ring framework. The most common heteroatoms are nitrogen, oxygen, and sulfur, although heterocyclic systems incorporating other heteroatoms have also been extensively reported.107 Depending on the number and type of heteroatoms present, a single ring may contain one or multiple heteroatoms, giving rise to diverse heterocyclic frameworks such as pyrazines, pyrimidines, oxazoles, and related analogues. These compounds are broadly classified into five- and six-membered heterocyclic systems based on the size of the ring.108 In addition to β-lactams, a wide variety of heterocyclic compounds can be synthesized through Staudinger reduction, Staudinger–aza-Wittig reactions, nucleophilic cyclization pathways, or by combining the Staudinger reaction with other complementary synthetic methodologies. Heterocyclic compounds constitute indispensable structural motifs in medicinal chemistry and are widely distributed in biologically important molecules, including natural products, vitamins, enzymes, and numerous pharmacologically active compounds. These heterocyclic scaffolds exhibit a broad range of biological activities, including antibacterial, antifungal, anti-inflammatory, antioxidant, antispasmodic, antiallergic, anti-HIV, antidiabetic, anticancer, insecticidal, herbicidal, and enzyme inhibitory properties. Representative heterocyclic compounds synthesized through Staudinger-based methodologies and their associated biological activities are summarized in Fig. 7.107 Biological role of heterocyclic compounds. Reproduced from ref. 107 with permission from Der Pharma Chemica, copyright © 2017. A wide variety of synthetic methodologies have been developed for the construction of heterocyclic compounds, including the Claisen rearrangement, Biginelli reaction, Fischer synthesis, intramolecular cyclization, [4+2] and [2+2] cycloaddition reactions, multicomponent reactions, transition metal-catalyzed C–H activation, microwave-assisted synthesis, solvent-free protocols, click chemistry, and numerous other synthetic strategies. Each of these approaches offers distinct advantages but also presents specific limitations with respect to substrate scope, reaction conditions, selectivity, scalability, or operational simplicity. In this review, particular emphasis is placed on the Staudinger reaction and its modern variants as an efficient and versatile synthetic platform for the preparation of structurally diverse five- and six-membered heterocyclic compounds. The following sections summarize recent developments in Staudinger-based methodologies and highlight their applications in the synthesis of biologically important heterocyclic scaffolds. Synthesis of acyl phosphoramidates employing a modified Staudinger reaction The N-acyl phosphoramides are a very significant structural feature of many biologically active natural products such as compound 38, and of the phosphonucleotide (phosphodosine) group of toxins. The biological relevance of their acyl phosphoramide structural unit is the fact that it is a more hydrolytically stable analogue of the acyl phosphate functionality, which is found in many metabolic processes. The many synthetic methods currently available include the phosphoramidite method, which is the most commonly used for the synthesis of phosphoramides, especially in the preparation of nucleotides, and which has been adapted to the synthesis of compound 141. While this is rather general, there are some drawbacks to it. It most particularly requires an oxidation step which is incompatible with thiols and other sulfur-containing functional groups. Furthermore, many functional groups require protection to be used with the highly reactive phosphorylating reagents, leading to greater synthetic steps and decreased efficiency. Other synthetic routes are also known, such as the direct phosphorylation of 144 and the acylation of preformed phosphoramides. However, these methods are usually based on deprotonation of the nitrogen atom before N-acyl phosphoramide 146 formation, and thus are not suitable for substrates with acid- or base-sensitive functional groups. Yet another reported method is the coupling of compound 147 and aldehydes in the presence of a ruthenium catalyst to produce N-acyl phosphoramides 148. This approach is synthetically promising, but it is limited by the need for an expensive catalyst that is not commercially available, ruthenium. In addition, the reaction may be accompanied by unwanted Curtius rearrangement side reactions, which decreases its usefulness. These drawbacks (Fig. 8) have encouraged the search for alternative, more practical syntheses (Scheme 26). Previous methods to synthesize phosphoramidates. Reproduced from ref. 109–113, with permission from RSC, ACS, and Walter de Gruyter, copyright © 2002, 1989, 2017, 2012 and 2009. Synthetic route to access phosphoramidates via Staudinger methodology. Reproduced from ref. 52 with permission from ACS, copyright © 2020. The Staudinger reaction is a well-established and efficient method for forming phosphorus–nitrogen bonds, producing an iminophosphorane intermediate. This intermediate is highly reactive towards oxygen-containing nucleophiles, particularly water and carbonyl compounds, where it typically decomposes to phosphine oxide plus an amine or imine. A more recent version, developed by Bertozzi and colleagues, follows a different pathway: instead of reacting with an external nucleophile, the iminophosphorane is rearranged intramolecularly to form an amide bond. Based on this concept, we describe here a modification similar to the Staudinger reaction, in which the iminophosphorane intermediate is rearranged to form compound 155. Hydrogen phosphonates (dialkylphosphonates) are valuable and versatile starting materials for the synthesis of phosphorus-containing molecules. This is precisely why attempts to use hydrogen phosphonates in reactions like the Staudinger reaction fail; there is simply not enough of the active isomer to complete the reaction. An ingenious solution is to adjust this by using a reagent with a strong affinity for oxygen; trimethylsilyl chloride TMS-Cl is a classic choice. Because TMS-Cl reacts selectively with oxygen (instead of phosphorus), it effectively traps the molecule in its phosphate-like reactive structure. Therefore, it is hypothesized that this TMS-activated intermediate 153 undergoes a 1,3-type internal migration, resulting in the repositioning of atoms within the molecule. When the reaction mixture is exposed to water during treatment, the temporary silyl group decomposes to an intermediate 154, revealing the final compound 155. It is worth noting that the 1,3 migrations of the silyl and acyl groups are well-documented in scientific literature and are mechanistically comparable to the Abramov reaction involving O-silyl phosphite. Based on this similarity, the researchers treated a mixture of dibenzyl hydrogen phosphonate 156 and benzoyl azide 151 using TMS-Cl with Et3N as the base. After purification by column chromatography, the desired phosphoramide product 157 was obtained at 88% purity (Scheme 27). Staudinger reaction scope by using compound 156. Reproduced from ref. 52 with permission from ACS, copyright © 2020. This approach was further extended by the use of compound 156 in the reaction with the readily available diphenylphosphoryl azide (DPPA) reagent, resulting in a range of imidodiphosphate 157 derivatives. The imidodiphosphate group acts as a mimetic of biologically important pyrophosphate, offering greater stability compared to its natural homologue. Further, compound 160 was used as a substrate for a Cope rearrangement to synthesize compound 161, and it was found that the primary limitation of this method was the thermal instability of compound 160. Compound 158 showed gradual decomposition at room temperature. In addition, aryl azides that have ortho substituents were unstable at room temperature (Scheme 28). Synthesis of compound 159via Staudinger reaction. Reproduced from ref. 52 with permission from ACS, copyright © 2020. To overcome this limitation, another method was developed for the in situ formation of compound 160. In this in situ method, compound 160 was first synthesized from compound 162 by using DPPA and DMF as solvent. Afterward, compound 152 and TMS-Cl were added to the reaction mixture. Lastly, DCM was added to prevent the precipitation of salt. After warming at room temperature, the desired product compound 161 was isolated and then purified (Schemes 29 and 30). Reaction scope using compound 160. Reproduced from ref. 52 with permission from ACS, copyright © 2020. Reaction scope by employing compound 162. Reproduced from ref. 52 with permission from ACS, copyright © 2020. Moreover, the utility of the Staudinger reaction was employed to synthesize compound 38. Its synthesis starts from compound 163, which was functionalized in one pot; the two-step procedure gives compound 165, a mixed ester in 77% yield. The product 38 was obtained as an inseparable mixture of P-epimers; consequently, all subsequent reaction products in this series were characterized and used as mixtures of stereoisomers. The main acylphosphoramide intermediate was generated via the in situ synthesis of compound 165, which was subsequently reacted with the corresponding hydrogen phosphonates in the presence of TMS-Cl to obtain the fully protected compound 166 at 64%. The overall protection of the N-tert-butoxycarbonyl (N-Boc) and tert-butyl ester groups was then removed by trifluoroacetic acid (TFA), yielding the treated form of compound 38 at 88%, which corresponds to an overall yield of 43% over the entire series (Scheme 31). Thus, it is concluded that the acyl phosphoramidates and their derivatives would be prepared best by using the new Staudinger method with maximum yield, as already mentioned above in the theory, as compared to the old methods that are mentioned in Fig. 8. The protocol demonstrated broad substrate compatibility, enabling the synthesis of 29 derivatives of 161, six derivatives of 159, and six derivatives of 157.114 Synthesis of compound 38 (antibiotic microcin C) via Staudinger reaction. Reproduced from ref. 52 with permission from ACS, copyright © 2020. Synthesis of poly substituted pyrazin-2(1H)-ones through a Ugi/Staudinger/aza-Wittig/isomerization sequence Pyrazinones are an important class of six-membered nitrogen-containing heterocyclic compounds that exhibit a wide range of biological and pharmacological activities. Their derivatives have attracted considerable attention because of their reported antitubercular, antidepressant, antiviral, anticancer, thrombin inhibitory, phosphodiesterase-5 (PDE5) inhibitory, and selective p38α MAP kinase inhibitory properties. Owing to these diverse biological activities, the pyrazinone scaffold has become an important target in medicinal chemistry. Naturally occurring compounds containing the pyrazinone framework include the marine-derived peptide JBIR-56 isolated from actinomycetes, as well as marinopyrazinones A and B obtained from Gram-negative bacteria. Several synthetic approaches to pyrazinone derivatives have previously been reported. For example, a variety of pyrazin-2(1H)-one derivatives have been synthesized through the cyclization of α-aminonitriles with compound 67. Under solid-phase conditions, gold-catalyzed intramolecular nucleophilic addition of N-propargyl peptides has provided 3,4-dihydropyrazin-2(1H)-ones in good to excellent purity. In addition, pyrazin-2(1H)-one derivatives have been prepared through ring transformation of meso-ionic 1,3-oxazolium-5-olates using tosylmethyl isocyanide (TosMIC), while multicomponent Ugi/deprotection/cyclization (UDC) and Ugi/deprotection/Heck sequences have also been successfully employed for the synthesis of structurally related pyrazinones. Despite these advances, many of the reported methodologies require harsh acidic reaction conditions, multiple synthetic steps, or expensive transition-metal catalysts, thereby limiting their practical applicability. Consequently, the development of efficient and mild synthetic strategies for the preparation of compound 174 remains an important objective in the synthesis of biologically active heterocyclic compounds. To address these limitations, an efficient one-pot sequential Ugi/Staudinger/aza-Wittig/isomerization strategy was developed for the synthesis of compound 174 (Scheme 32). Four-component one-pot synthesis of compound 174 through a Ugi/Staudinger/aza-Wittig/isomerization sequence. Reproduced from ref. 100 with permission from ACS, copyright © 2021. The synthetic procedure was initiated by dissolving compounds 167 and 170 in methanol, followed by stirring at room temperature for 10 min. Subsequently, compounds 168 and 169 were added successively, and the reaction mixture was stirred at room temperature for 12–24 h, with the reaction progress monitored until completion. After evaporation of the solvent under reduced pressure, toluene or 1,4-dioxane was added to 171, followed by the addition of PPh3 dissolved in the corresponding solvent, forming the intermediates 172 and 173. The mixture was stirred at room temperature for 2–4 h to complete the Staudinger reaction, after which it was heated at 115 °C in an oil bath for 6–12 h to promote the aza-Wittig cyclization and subsequent isomerization. Upon completion, the solvent was removed under reduced pressure, and the crude product was purified by silica gel column chromatography using a petroleum ether/ethyl acetate (4 : 1–2 : 1) solvent system to afford compound 174, yielding derivatives of compound 174 with an 83% success rate, compared to a 75% yield when using the stepwise method. To illustrate substrate versatility, 20 derivatives of compound 174 were synthesized. The process was limited to a 1 mmol scale and exhibited a keto/enol balance of roughly 1 : 4 through a 1,5-H shift isomerization mechanism. The use of stoichiometric PPh3 acted as a limitation from a green chemistry perspective. This sequential Ugi/Staudinger/aza-Wittig/isomerization methodology provides a practical and efficient route to compound 174 and its derivatives under mild one-pot reaction conditions. The use of readily available four-component starting materials, combined with operational simplicity and broad synthetic applicability, makes this strategy an attractive approach for the preparation of pyrazinone derivatives with potential pharmaceutical and biological significance.100 Synthesis of polysubstituted 3,4-dihydroquinazolines 3,4-Dihydroquinazolines are an important class of nitrogen-containing heterocycles that continue to attract considerable attention because of their presence in numerous biologically active natural products and pharmaceutical agents. A wide range of 3,4-dihydroquinazoline derivatives has been reported to exhibit diverse pharmacological activities, including anticancer, antiviral, antidepressant, antifungal, selective somatostatin receptor subtype-2 (SST2) agonistic, β-site amyloid precursor protein-cleaving enzyme-1 (BACE-1) inhibitory, and cholinesterase inhibitory properties. In addition, naturally occurring alkaloids such as vasicine and vasicoline possess the 3,4-dihydroquinazoline framework. Consequently, numerous synthetic methodologies have been developed for the preparation of these biologically significant heterocycles. Several efficient synthetic approaches have been reported in the literature. For example, 3,4-dihydroquinazolines have been synthesized in good yields through triflic anhydride (Tf2O)-mediated amide dehydration, followed by ketimine addition and Pictet–Spengler-type cyclization. Other reported methods include copper-catalyzed oxidative cross-coupling of hydroxy intermediates with various nucleophiles and intramolecular aza-Baylis–Hillman cyclization. Despite these advances, many of these procedures require harsh reaction conditions, expensive catalysts, or multistep synthetic sequences. Therefore, the development of mild, efficient, and operationally simple methodologies for the synthesis of compound 182 remains highly desirable. To address these limitations, an efficient Passerini/Staudinger/aza-Wittig/addition/nucleophilic substitution sequence was developed for the synthesis of compound 182. The synthetic sequence commenced by reacting compounds 175, 176, and 177 in dichloromethane (CH2Cl2) at room temperature for 48 h. The three-component Passerini reaction proceeded smoothly to afford compound 178 in an 87% yield. Subsequently, compound 178 was subjected to a Staudinger reaction with triphenylphosphine (PPh3) in CH2Cl2 at room temperature for 2 h, generating the corresponding iminophosphorane intermediate 179. Without isolation, compound 179 underwent an aza-Wittig reaction with phenyl isocyanate to produce compound 180, which was subsequently treated with diethylamine to furnish the intermediate compound 181. In the final step, compound 181 underwent intramolecular nucleophilic substitution in acetonitrile (CH3CN) under reflux in the presence of potassium carbonate (K2CO3), affording the desired compound 182 in an 84% yield and proceeding in the absence of a metal catalyst, utilizing only stoichiometric amounts of PPh3 and K2CO3. Reaction optimization demonstrated that stronger bases, including sodium hydroxide (NaOH) and sodium ethoxide (EtONa), resulted in the formation of a dark reaction mixture accompanied by significant side reactions, preventing the formation of the desired product (Scheme 33). Conversely, the use of the weaker base Et3N in CH3CN failed to promote cyclization, and no product was obtained. In addition, the influence of various R-group substituents on reaction efficiency was systematically investigated to evaluate their effect on the overall yield. Preparation of compound 182. Reproduced from ref. 101 with permission from Beilstein-Institut, copyright © 2022. Overall, this methodology provides an efficient one-pot synthetic route for the preparation of compound 182 under mild reaction conditions. The protocol employs readily available starting materials, accommodates a broad range of substituents, and affords the desired products in good to excellent yields, highlighting its practicality and versatility for the synthesis of compound 182 derivatives.101 ortho-Phosphinoarenesulfonamide-mediated Staudinger reduction One of the most used methods for preparing amino compounds in chemical synthesis is the Staudinger reduction. Trivalent phosphines, mainly triphenylphosphine, are used in the traditional Staudinger process to reduce compound 183 in an aqueous environment through an aza-ylide (or iminophosphorane) intermediate. As a result, the system's water content has a major impact on the Staudinger reduction rate, especially when dealing with extremely hydrophobic substrates. To encourage the breakdown of the aza-ylide intermediate into compound 184 and 185, a significant excess of water is usually needed. In order to overcome these difficulties, Li et al. discussed the use of compound 187 as a novel reagent for the Staudinger reduction of compound 186 in both anhydrous and aqueous conditions. Compound 186 was dissolved in anhydrous tetrahydrofuran THF under a nitrogen atmosphere, and the reagent was added directly, and water was not added. When mixed, the phosphine nucleophilically reacts with the terminal nitrogen on compound 186 to produce a betaine intermediate, which subsequently releases N2 gas to produce an aza-ylide intermediate. Upon completion, the mixture was concentrated under low pressure and purified by flash column chromatography to obtain the pure compound 188. In comparison with traditional Staudinger reductions where an outside water supply is required to break up this aza-ylide, the action of compound 187 of reagent acts orally on the aza-ylide nitrogen to release compound 188, yet also to form a stable compound 189 (Scheme 34). The reaction took 3 hours at 30 °C to give isolated yields of 85–99% in the case of aromatic azides, and 60 °C in 15 hours to give yields of 78–96% in the case of aliphatic azides. The methodology demonstrated broad substrate compatibility, encompassing three derivatives of 187 and 22 derivatives of 188. As the transformation involved a stereoretentive reduction, stereoselectivity was not a determining factor. The reaction was performed on a 5 mmol (1.21 g) scale using a stoichiometric amount of 187. Notably, the protocol eliminated the need for water, unlike conventional Staudinger reductions, thereby improving its sustainability and representing the first water-free Staudinger reduction catalyzed by 187. Phosphine-mediated Staudinger reduction of compound 183 and 186. Reproduced from ref. 27 with permission from Molecules, copyright © 2022. Enantioselective synthesis of quaternary oxindoles via desymmetrizing Staudinger–aza-Wittig reaction enabled by a bespoke hypPhos oxide catalyst Organophosphorus compounds are effective reagents for the Wittig and aza-Wittig reactions that create C–C and C–N bonds. Catalytic enantioselective variations of Wittig and aza-Wittig reactions using a PIII/PV Created by potrace 1.16, written by Peter Selinger 2001-2019 O redox cycle are uncommon, despite the fact that numerous catalytic variants of these reactions have been established to prevent the generation of phosphine oxide waste—by means of a silane-mediated PIII/PVO redox cycle. In a previous study, using our chiral phosphine HypPhos 1, we created a catalytic asymmetric Staudinger–aza-Wittig reaction of 1,3-diones for the synthesis of heterocyclic amines. Considering the significance of the Staudinger–aza-Wittig reaction for the synthesis of heterocycles, we questioned whether chiral lactams could be accessed via a Staudinger–aza-Wittig reaction and used to synthesize complex alkaloids. Because of the relatively low reactivity of esters and the challenges of asymmetric induction, we employed a specially developed HypPhos oxide catalyst, 2˙[O], in the synthesis of useful compound 191via collaborative IrI–PIII/PVO redox cycles via asymmetric Staudinger–aza-Wittig reaction. They use a custom-designed HypPhos oxide catalyst 2[O] with a strained compound 190, phenylsilane as the terminal reductant in P[v]PO redox cycling, and [Ir(cod)Cl]2 as a Lewis acid with TBABF4 to exchange chloride ions. The optimized conditions involve cyclohexane as solvent at 45 °C, 24–72 hours. The catalytic process takes place in a series of steps starting with the reaction of compound 190 with the catalytic phosphorane to produce an iminophosphorane form of intermediate. TetramethylammoniumIrI Lewis acid binds to the malonate ester, making it more electrophilic. The resultant imidate breaks up during workup to the lactam (oxindole), leaving compound 191 intact. This phosphine oxide is reduced by phosphine with the help of iridium, and a turnover of the catalyst is made possible (Scheme 35). A stepwise retro-[2+2] cycloaddition of the iminophosphorane and the activated ester to form an oxazaphosphetane intermediate and consecutive stepwise [2+2] cycloaddition is used to break P–N and C–O bonds one after another. Scaled-up Staudinger–aza-Wittig reaction. Reproduced from ref. 102 with permission from ACS, copyright © 2022. The methodology exhibited broad substrate scope, encompassing four derivatives of 192 and 46 derivatives of 191. Products were obtained in 81–92% yields with excellent enantioselectivities of up to 97% ee, while X-ray crystallography confirmed the (S)-configuration. The phosphine-based catalytic system and mild reaction conditions (35–45 °C) enhanced the sustainability of the protocol; however, the requirement for silane and Ir catalysts remained a limitation. Thus, they created an asymmetric Staudinger–aza-Wittig reaction of (o-azidoaryl) malonates, which is catalyzed by phosphine oxide and gives access to a variety of useful compound 192 (Scheme 35). Stereoselective synthesis of 12-tetrazolyl substituted (E)-5H-quinazolino[3,2-a]quinazolines Tetrazoles are synthetic nitrogen-containing heterocyclic compounds characterized by a five-membered ring comprising four nitrogen atoms and one carbon atom. Tetrazole derivatives exhibit a broad range of biological activities, including antiviral, anticancer, antifungal, and anti-Alzheimer properties. Moreover, several clinically important drugs, such as valsartan and losartan, contain the tetrazole ring as a key pharmacophore. Likewise, quinazolines and their fused-ring derivatives display diverse pharmacological activities, including anti-inflammatory, antiproliferative, antifungal, antitumor, antimicrobial, δ-selective phosphoinositide 3-kinase inhibition, and agonistic activity toward the constitutive androstane receptor (CAR).115 In recent years, the combination of the Ugi multicomponent reaction with subsequent cyclization strategies has emerged as an efficient approach for the synthesis of structurally diverse heterocyclic compounds. For example, highly functionalized pyrrolo[1,2-a]pyrazine-3,6(2H,4H)-diones have been synthesized in good to excellent yields through tandem cyclization followed by Au(i)-catalyzed regioselective annulation. Similarly, pyrrolopiperazine-2,6-diones have been prepared in high yields and with excellent diastereoselectivity through a sequential Ugi reaction, nucleophilic substitution, N-acylation, and debenzoylation. Among the available cyclization methodologies, the aza-Wittig reaction remains one of the most efficient approaches for the construction of nitrogen-containing heterocyclic frameworks. Building upon the synthetic utility of the Ugi and aza-Wittig reactions, a new stereoselective strategy was developed for the synthesis of compound 21 through a sequential Ugi-azide/Staudinger/aza-Wittig/addition/Ag(i)-catalyzed cyclization sequence. The synthesis commenced with the Ugi-azide reaction, in which compounds 193, 194, 195, and 196 were stirred in methanol at room temperature for 12–24 h. The reaction proceeded efficiently, affording compound 197, which precipitated directly from the reaction mixture in 72–90% yield. Compound 197 was subsequently selected as the key intermediate for the following transformations (Scheme 36). Treatment of compound 197 with PPh3 in toluene at room temperature initiated the Staudinger reaction, generating the corresponding iminophosphorane intermediate 198. Without isolation, compound 198 was carried directly into the next reaction step. At room temperature, no reaction occurred between compounds 198 and 199, and compound 200 was not formed. Preparation of compound 197via Ugi-azide reaction. Reproduced from ref. 20 with permission from ACS, copyright © 2023. However, upon heating the reaction mixture to 110 °C in the presence of AgNO3 as the catalyst and K2CO3 as the base, the sequential Staudinger/aza-Wittig/addition process proceeded smoothly, furnishing compound 21 in an excellent 83% yield (Scheme 37).20 Preparation of compound 21 agi-azide/Staudinger/aza-Wittig/addition/Ag(i)-catalyzed cyclization. Reproduced from ref. 20 with permission from ACS, copyright © 2023. Under thermodynamic control, the reaction proceeded with high E-selectivity (up to 100 : 0). The methodology was extended to 18 derivatives of compound 21 and 10 derivatives of compound 197. The process was successfully demonstrated at the gram scale (81% yield). However, the reflux temperature of 110 °C and the use of a precious-metal (Ag) catalyst were identified as disadvantages for green chemistry considerations. Overall, this methodology provides an efficient and stereoselective route for the synthesis of compound 21 under comparatively mild reaction conditions. The sequential Ugi-azide/Staudinger/aza-Wittig/addition/Ag(i)-catalyzed cyclization strategy affords the desired product in excellent yield (83%) with high stereoselectivity, demonstrating its effectiveness as one of the most practical and reliable approaches reported for the preparation of compound 21 (Scheme 37).20,103 Stereoisomeric edoxaban synthesis by the use of stereoisomeric deoxyamination Compound 35 is an orally active factor Xa (FXa) inhibitor developed by Daiichi Sankyo Co., Ltd. Following its approval by the U.S. Food and Drug Administration (FDA) in 2015, it has been marketed under the trade names Savaysa and Lixiana for the prevention and treatment of venous thromboembolism. Owing to its efficacy and favorable safety profile, it has become one of the most widely prescribed anticoagulant drugs worldwide. A major challenge in the large-scale synthesis of compound 35 using the original Daiichi Sankyo process is the incorporation of the azide functionality, owing to the safety concerns associated with azide intermediates and the need to minimize the formation of undesired diastereomers. To address these limitations, the authors identified stereoinverting deoxyamination of the corresponding alcohol as the key transformation for the preparation of the amine with the desired stereochemistry. The objective was to develop a reaction that proceeds under mild conditions, employs safer reagents, and affords high levels of diastereoselectivity. The reported methodology combines Bose–Mitsunobu azidation with a subsequent Staudinger reduction to access key intermediates of compound 35 through stereoinverting deoxyamination. Importantly, the process was designed as a one-pot protocol, thereby eliminating the need to isolate the potentially hazardous azide intermediate 202. In the first step, the alcohol was converted into compound 202 by Bose–Mitsunobu azidation using diphenylphosphoryl azide (DPPA) as the azide source, together with diisopropyl azodicarboxylate (DIAD) and triphenylphosphine in toluene or methyl tert-butyl ether (MTBE) at 25 °C for 21 h. The resulting reaction mixture was then directly treated with triphenylphosphine (2.0 equiv.), initiating the Staudinger reaction. This step proceeded with vigorous evolution of nitrogen gas to generate the corresponding iminophosphorane intermediate 203. Subsequent hydrolysis of compound 203 with 4 equiv. of water at 50 °C for 44 h afforded compound 204. Isolation of compound 206 as either the oxalate or camphorsulfonate salt was achieved by addition of the appropriate acid 205 followed by precipitation with isopropanol (IPA) or acetone, providing an overall yield of 77–81% with excellent diastereoselectivity (dr = 1 : 0.004–1 : 0.01) (Scheme 38). Furthermore, replacement of the tert-butoxycarbonyl (Boc) protecting group with compound 207 significantly improved both the reaction yield and the diastereoselectivity. Synthesis of compound 35via Bose Mitsunobu azidation and Staudinger reaction. Reproduced from ref. 49 with permission from ACS, copyright © 2023. Although the substrate scope remained restricted to protecting-group, reagent, and phosphine variants within a single-target process study. By substituting the explosive reagent NaN3 with DPPA under ambient conditions, the approach was demonstrated at a 20.0 g scale with DSC safety testing and marked a significant advancement in green chemistry and safety. Overall, compound 35 was efficiently synthesized through a stereoinverting deoxyamination strategy integrating Bose–Mitsunobu azidation and the Staudinger reaction under mild conditions with neighboring-group participation. The one-pot protocol eliminated the isolation of hazardous azide intermediates while providing key synthetic intermediates in high yield and stereoselectivity. Synthesis of luminescent indolo[2,1-b] quinazolin-6(12H)-ones via a sequential Ugi/iodine-promoted cyclization/Staudinger/aza-Wittig reaction Indoloquinazolinones constitute an important class of nitrogen-containing heterocyclic compounds that exhibit a broad spectrum of biological and pharmacological activities. Numerous indoloquinazolinone derivatives have been reported to possess selective protein-binding activity as well as anticancer, antibacterial, antifungal, and casein kinase 2 inhibitory properties. In addition, the indoloquinazolinone framework is present in several naturally occurring products, including tryptanthrin, methylisatoid, and cephalanthrine. Owing to their unique structural features and significant biological potential, a variety of synthetic approaches toward indoloquinazolinones have been described in the literature. These include Pd/Ag-catalyzed double annulation of o-aminoacetophenones with isocyanates, Cu(OTf)2-catalyzed intramolecular dearomative amination of N-acylindoles using the synergistic tert-butyl hydroperoxide TBHP/tripotassium phosphate K3PO4/trifluoromethanesulfonic acid TfOH system, and oxidative domino cyclization of isatins to afford pharmaceutically relevant indoloquinazolinone derivatives. Despite the effectiveness of these methodologies, many suffer from limitations such as restricted substrate scope, harsh reaction conditions, and the requirement for expensive catalysts. The synthesis commenced with the reaction of compounds 208, 209, and 210 in dichloromethane (CH2Cl2) at room temperature in the presence of a catalytic amount of phenylphosphinic acid. The Ugi three-component reaction proceeded smoothly over 24–48 h, and compound 211 was isolated in excellent yields (60–92%) following purification by column chromatography (Scheme 39). Preparation of compound 211via Ugi-3CR. Reproduced from ref. 103 with permission from ACS, copyright © 2023. Subsequently, compound 211 was selected as the model substrate for the reaction sequence. Initially, it was treated with molecular iodine (I2)/dimethyl sulfoxide (DMSO) to promote an intramolecular C–N amidation of the alkyne and amine functionalities, affording compound 212. The resulting intermediate 212 was then subjected to the Staudinger reaction with triphenylphosphine to generate the corresponding iminophosphorane intermediate, which subsequently underwent an intramolecular aza-Wittig cyclization to furnish the desired product 213 with a yield of 60–92% (Scheme 40). Notably, all of the synthesized compounds exhibited intense red or orange coloration, indicating their potential utility as dye materials. Furthermore, UV-visible spectroscopic analysis revealed that the maximum absorption wavelengths (λabs) of the representative compounds ranged from 487.0 to 511.0 nm, demonstrating favorable photoelectronic properties. Only two derivatives of compound 209 were available. Interestingly, no metal catalyst was employed at any point in the process, which is a positive aspect of green chemistry. Preparation of compound 213. Reproduced from ref. 103 with permission from ACS, copyright © 2023. Furthermore, literature studies investigating the photoelectronic properties of various derivatives of compound 213 have demonstrated that several of these compounds exhibit promising luminescent characteristics.103 Synthesis of bench-stable polycyclic organophosphorus heterocycles via Staudinger-type annulations of ortho-azido phenols The discovery of new heterocyclic and polycyclic frameworks continues to expand the accessible chemical space and provides opportunities for the development of molecules with unique structural and functional properties. Among the various synthetic strategies employed to access previously unexplored heterocyclic architectures 217, from compounds 215 and 216, atom substitution—the replacement of one or more atoms within an existing ring system by heteroatoms—has emerged as an effective and versatile approach. In particular, the design and synthesis of novel phosphorus-containing heterocycles have been guided by the concept of “phosphorus as a carbon analogue”, which was originally proposed to describe the structural and electronic similarities between low-valent and coordinated phosphorus species and their carbon counterparts. Although numerous phosphorus heterocyclic compounds have been reported in recent decades, bench-stable pentacoordinate phosphorus derivatives remain relatively uncommon. A major limitation of pentacoordinate phosphorus compounds 220 is their pronounced susceptibility to hydrolysis. In addition, steric congestion around the pentavalent phosphorus center 218 often promotes conversion to the thermodynamically more stable tetracoordinated species upon treating with compound 219. To overcome these limitations, the incorporation of additional fused or annulated cyclic frameworks into the molecular architecture has emerged as an effective strategy for enhancing the stability of pentacoordinated phosphorus compounds (Schemes 41 and 42). Strategy to synthesize ring-stabilized compound 217. Reproduced from ref. 116 with permission from John Wiley & Sons, copyright © 2024. Strategy to synthesize the ring-stabilized compound 220. Reproduced from ref. 116 with permission from John Wiley & Sons, copyright © 2024. Building on this concept, this research group recently demonstrated that the concurrent formation of trimethylsilyl fluoride (Me3SiF) and molecular nitrogen (N2), both thermodynamically favorable byproducts, provides a strong driving force for cyclic addition reactions that are otherwise difficult to accomplish under conventional reaction conditions (Scheme 43). Annulation driven by the formation of TMSF and N2. Reproduced from ref. 116 with permission from John Wiley & Sons, copyright © 2024. This strategy enabled the synthesis of a new phosphorus-containing heterocyclic framework 222, benzo-1,2,3-thiazaphosphole (B-TAP), through a Staudinger-type annulation of ortho-phosphinoarenesulfonyl fluoride 221 with trimethylsilyl azide 196. Building upon this methodology, the present study extended the synthetic approach to constructing a novel in vitro-stable pentacoordinated polycyclic phosphorus(v) framework, compound 226, together with its carbonyl-containing analogue, compound 227. Specifically, it was proposed that the annulation of compound 221 with compound 223, in the presence of a silicon-based additive, would afford an unprecedented [5,5,0]-bicyclic P(v) scaffold (Scheme 44).104 Synthesis of compounds 226 and 227via Staudinger-type annulation with compound 223. Reproduced from ref. 116 with permission from John Wiley & Sons, copyright © 2024. This methodology achieved compound 226 in 93% optimized yield and compound 227 in 82% yield at the gram scale, with substrate scope spanning 24 derivatives of compound 226 and 12 derivatives of compound 227. Gram-scale synthesis (5 mmol, 82% yield) was demonstrated without the need for chromatographic purification, although multiple solvents (MeCN, THF, DMSO, DMF, CHCl3, toluene) were compared solely for yield optimization rather than sustainability. Isolation of a Staudinger-type intermediate utilizing a five-membered phosphorus-centered biradicaloid Pilopp and co-workers investigated the reaction of covalent azides with the phosphorus-centered cyclic compound 228, revealing a multistep reaction pathway leading to the formation of Staudinger-type products. Before this study, none of the type I Staudinger-type intermediates associated with the classical Staudinger reaction had been successfully isolated through a biradicaloid–azide reaction pathway. To minimize ring strain and steric congestion, the authors employed a five-membered diphosphorus biradicaloid 233 instead of the previously studied systems. This strategy enabled the successful isolation of a transient Staudinger-type intermediate 232, which was stabilized at low temperatures by the diphosphorus-centered biradicaloid 233 (Scheme 45). Reaction of compound 228 and 231 to isolate compound 232 (R = Mtp = 2,6-dimethyl-4-tert-butyl-phenyl; Ter = 2,6-dimesityl-phenyl). Reproduced from ref. 117 with permission from John Wiley & Sons, copyright © 2025. The five-membered phosphorus-centered heterocyclic compound 231 was synthesized in excellent yield (82%) by treating compound 228 dissolved in benzene with an equimolar amount of 2,6-dimethyl-4-tert-butylphenyl isonitrile (Mtp–NC; Mtp = 2,6-dimethyl-4-tert-butylphenyl). Upon mixing the reactants, the solution underwent an immediate color change from orange to deep blue, corresponding to the characteristic color of the biradical intermediate. Using the readily isolated blue compound 231, the authors subsequently investigated its reactivity toward covalent organic azides. For this purpose, compound 231 was allowed to react with two different organic azides in benzene (Scheme 46). After solvent removal followed by recrystallization from n-hexane, colorless crystalline products were isolated in both cases and identified as Staudinger-type intermediates 235 and 237 in yields of 53% and 40%, respectively. Single-crystal X-ray diffraction analysis unequivocally confirmed the formation of these intermediates, demonstrating that the terminal (γ) nitrogen atom of the azide is coordinated simultaneously to both phosphorus atoms of the diphosphorus biradicaloid. The substrate scope was restricted to two large aryl azides 234 and 236. Scalability was limited to a small-scale, low-temperature, rapid-isolation approach. This bonding mode differs fundamentally from that of the classical Staudinger intermediate, in which the azide is bonded to only a single phosphorus atom.105 Synthesis and isolation of Staudinger-type adduct from compound 233. Reproduced from ref. 117 with permission from John Wiley & Sons, copyright © 2025. Synthesis of diamido N-heterocyclic imines (DACNH) via Staudinger or reductive N–N bond cleavage approach For more than a century, the Staudinger reaction between organic azides and phosphines has served as a reliable method for the synthesis of iminophosphoranes (RNPR'3). Following the establishment of N-heterocyclic carbenes (NHCs) as stable and well-defined species, Bielawski and Tamm, independently, extended this transformation to NHCs, thereby enabling the synthesis of NHCNR derivatives. However, no previous studies had reported the reaction of diamidocarbenes (DACs) with compound 147. Consequently, the present work sought to expand the family of nitrogen-containing heterocyclic imines (NHIs) through the synthesis of DACNH derivatives. Using a modified Staudinger protocol, a DACNH derivative 240 was successfully prepared from a five-membered diamidocarbene 238. In contrast, the same reaction conditions proved ineffective for the corresponding six-membered DAC. Treatment of compound 238 with an excess of compound 196 resulted in an immediate color change from red to colorless, and stirring the reaction mixture at room temperature for 12 hours afforded the corresponding N-silylated diamidoimine in 80% yield (Scheme 47). Synthesis of compound 240via Staudinger reaction. Reproduced from ref. 106 with permission from ACS, copyright © 2025. The Staudinger reaction was unsuccessful in the synthesis of six-membered DAC-based nitrogen-containing heterocyclic imines (NHIs) because of competing intramolecular C–H insertion. Instead, the corresponding DAC-based azine 3 was obtained by reacting the in situ-generated six-membered DAC-Dipp with trimethylsilyldiazomethane (Me3SiCHN2) in toluene at room temperature for 20 h, followed by purification by column chromatography. Instead of using a metal catalyst, stoichiometric Me3SiN3196 or HCl was utilized, which eliminated the necessity for Rh-or KC-mediated N–N cleavage. Unexpectedly, treatment of compound 241 with hydrochloric acid (4 M in dioxane or aqueous HCl) resulted in an unusual N–N single-bond cleavage, leading to the formation of the first example of compound 242 in 61% yield (Scheme 48).106 The modest scope of the substrate, which included seven derivatives of compound 239, concentrated on comparing the ring sizes of DAC systems with five and six members 238vs.241. Reactions were only observed at a small scale using NMR tubes. Synthesis of compound 242via N–N bond cleavage of compound 241. Reproduced from ref. 106 with permission from ACS, copyright © 2025. Synthesis of triazinyl phosphoramidate oligonucleotides Modified oligonucleotides are now widely used in molecular biology, biotechnology, and medicine because of their enhanced stability and functional properties compared with unmodified oligonucleotides. Their principal applications include use as polymerase chain reaction (PCR) primers, molecular beacons, and therapeutic agents, where they often exhibit superior performance relative to their native counterparts. Compound 248 represents a promising class of modified oligonucleotides because it can be synthesized using several well-established methodologies, and its molecular structure permits versatile functional-group modification. Among the available synthetic approaches, the Staudinger reaction has emerged as an efficient strategy for the preparation of phosphoramidate derivatives. In previous studies, a method was developed for incorporating a triazinyl phosphoramidate group bearing two dodecyl substituents into an oligonucleotide framework. This strategy is based on the Staudinger reaction between compound 243, the phosphite triester intermediate generated during the oligonucleotide synthesis cycle, and compound 244, which functions as both the oxidizing and modifying reagent. Subsequent substitution of compound 246 affords the corresponding phosphoramidate derivative, compound 248. This triazinyl phosphoramidate containing two dodecyl groups was found to possess favorable physicochemical properties. Consequently, the synthetic methodology for preparing compound 248 was investigated in detail, including optimization of triazinyl phosphoramidate oligonucleotide (TPO) synthesis, variation of substituents on the triazine core, and the use of differently substituted azidotriazines as modifying reagents. Mechanistically, the reaction begins with the Staudinger coupling of compound 244 with the reactive phosphite triester intermediate 243 of the growing oligonucleotide chain, resulting in the formation of compound 245, which contains a P–N bond. Following completion of the Staudinger reaction, compound 246 is treated with appropriate anhydrous amine solutions to introduce the desired functional groups, yielding compound 247. Subsequent conversion to compound 248, followed by cleavage of the modified oligonucleotide from the controlled pore glass (CPG) solid support, affords the desired triazinyl phosphoramidate oligonucleotide in a yield of 40–95% (Scheme 49). Since the phosphorus center was still uncertain, stereoselectivity was not applicable. Synthesis of compound 248via a Staudinger reaction using compound 244. Reproduced from ref. 33 with permission from the ACS, copyright © 2025. The approach was expanded to include 18 derivatives of compound 248. A custom-synthesized azide reagent was needed for the synthesis, which was carried out at a tiny (oligonucleotide) scale of 0.4 µmol. In this study, it was demonstrated that a wide range of functional groups, including dodecyl substituents, can be incorporated into the triazine core of compound 244 through modification of a single compound 243 unit. This strategy enables the introduction of diverse functionalities into the oligonucleotide, thereby allowing modulation of its physicochemical and biological properties. Consequently, compound 248 represents a unique class of phosphate-modified nucleic acids with considerable structural diversity and broad potential for applications in molecular biology, biotechnology, and therapeutic development.33 Unified synthesis of (+)-aspidophylline A via a BIBOP-catalyzed asymmetric Staudinger/aza-Wittig reaction Compound 34 is a complex pentacyclic monoterpene indole alkaloid belonging to the akuammiline family. It was first isolated from the stem bark of Kopsia singapurensis, a Malaysian medicinal plant. Structurally, compound 34 possesses a highly intricate cage-like framework comprising five contiguous stereogenic centers embedded within a cyclohexane core, a bridged piperidine ring, and an indoline moiety fused to a tetrahydrofuran ring. Biologically, it has attracted considerable interest because of its potential to overcome multidrug resistance in human KB nasopharyngeal carcinoma cells. Owing to its unique molecular architecture and promising biological activity, compound 34 has become an important target for total synthesis.118 Intramolecular cyclization of this intermediate then furnishes the tetracyclic core through an enantioselective desymmetrization process, providing efficient access to the molecular framework of compound 34 (Scheme 50). This procedure used an organocatalytic method using a catalytic system of BIBOP (20 mol%), Brønsted acid, and PhSiH3. For the total synthesis of compound 34, an enantiomerically enriched tricyclic indole derivative was selected as the starting material. Triflation using N-phenyl-bis(trifluoromethanesulfonimide) (PhNTf2) and sodium hexamethyldisilylamide (NaHMDS) afforded compound 250 in 91% yield. Palladium-catalyzed carbonylative esterification subsequently produced compound 251, and removal of the tert-butyldimethylsilyl (TBS) protecting group with camphorsulfonic acid (CSA) furnished compound 252 in excellent yield. An intramolecular azido-alkoxylation of compound 252 introduced the N-2 functionality, with an unresolved diastereomeric ratio of roughly 1 : 1, yielding compounds 253 and 254 in 45% yield each. Finally, Staudinger reduction converted the azide 253 into the corresponding primary amine, which was alkylated with (Z)-1-bromo-2-iodobut-2-ene to afford the corresponding secondary amine. This intermediate has previously served as an advanced precursor in the total synthesis of compound 34 (Scheme 50). The process was expanded to 16 derivatives of compound 249, and a significant green chemistry advantage was provided by the catalytic (as opposed to stoichiometric) usage of the phosphorus catalyst, which prevented Ph3PO waste production. Enantioselective formal synthesis of compound 34. Reproduced from ref. 47 with permission from John Wiley & Sons, copyright © 2026. Accordingly, a unified asymmetric Staudinger/aza-Wittig–imine cyclization strategy catalyzed by the chiral bisphosphine catalyst bibenzo[d][1,3]oxaphosphole (BIBOP) has been developed, providing an efficient and stereoselective approach to the synthesis of the tetracyclic core structures of diverse monoterpene indole alkaloids, including compound 34.47 Critical perspectives and research gaps Critical perspectives and research gaps in beta-lactam synthesis The Staudinger reaction approaches to compound 51 reported indicate that most of the recent innovations have been on the ketene side and few on the imine side. The standard method using acid chlorides and Et3N to generate ketene in situ continues to work, but is hampered by the moisture sensitivity and awkward handling of acid chlorides. To address these drawbacks, other methods have been developed, such as in situ mixed-anhydride/TsCl activation and the photochemical Wolff rearrangement of diazo-compounds. The TsCl mediated approach is an important improvement due to the stability of TsCl and high reaction efficiency and selectivity. Similarly, the Wolff rearrangement can be used to prepare ketenes in an acid chloride free step with substitution patterns that are not easily accessible through traditional methods. Reaction medium, the electronics of the substrate, and the ketene-generation strategy can have a significant effect on the stereochemical outcome of the Staudinger reaction. The use of different solvents and ketene precursors changes the diastereoselectivity, and can be optimized. In the general case, alkoxy- and aryloxy-substitued ketenes tend to give the cis-β-lactam, while aryl- and alkyl-substituted ketenes give the corresponding trans-β-lactam. In addition, the lifetime of the zwitterionic intermediate is influenced by the polarity of the solvent and the reaction temperature, and thus the torquoselectivity and a generalized electronic model for stereochemical control. Critical perspective and research gaps in heterocyclic synthesis The literature reviewed in this article highlights the remarkable evolution of the Staudinger reaction from a simple phosphine–azide transformation into a highly versatile synthetic platform for the preparation of phosphoramidates, structurally complex N-heterocycles, and chiral alkaloid frameworks. The successful combination of the Staudinger reaction with multicomponent reactions such as the Ugi reaction, Passerini reaction, Mitsunobu reaction, and Staudinger–aza-Wittig sequences has significantly broadened the synthetic applications of this reaction. Yet, there are a number of problems that hinder the widespread adoption of Staudinger-based methodologies. A multitude of asymmetric protocols are based on costly transition metal catalysts or specially designed chiral phosphine ligands, such as iridium-, silver-, HypPhos- or BIBO-based catalytic systems, that are often only moderately efficient for sterically demanding, aliphatic, and highly reactive substrates. Furthermore, while excellent enantioselectivities are possible in a few examples, it is hard to obtain a high stereocontrol over a wide variety of substrates. Moreover, the mechanism of recently reported transformations, such as unusual pathways of N–N bond cleavage and formation of biradicaloid intermediates, is not fully understood and relies on isolated investigations rather than systematic mechanistic studies. Future perspectives Although the Staudinger reaction has been successfully used to prepare numerous compounds, there are some issues that need to be addressed to make it more scalable, efficient, and widely applicable. The scope of substrate for continuous-flow methodologies should be extended beyond model substrates to include other electron rich and electron-poor aromatic systems, and to other heteroaryl imines in the future. Such research would prove flow chemistry as a synthetic tool, and not a proof-of-concept. The synthesis of structurally complex spiro- and bis-spiro frameworks in an efficient manner is another direction of interest. Design of shorter or telescoped or catalytic synthetic routes, especially ones that are amenable to continuous flow processes, would make these compounds more accessible for use in practice. Another area of promising research is the combination of real-time analytical techniques (in-line LC-MS and NMR spectroscopy) with modern ketene-generation and continuous-flow platforms. An integrated system would allow for the monitoring of reactions in real time, allow for the optimization of reaction conditions, and provide a more in-depth understanding of the reaction mechanism that existed beyond the end point analysis. In addition, future research should not be restricted to the synthesis of compound 51, but should also cover a variety of other compounds synthesized using the Staudinger reaction, which have important biological and pharmaceutical applications. Therefore, the development of synthetic methods needs to go hand in hand with the biological and functional evaluation as from the beginning of investigation to shorten the time required to identify therapeutically relevant compounds. In the same way, the identification of inexpensive, metal-free or recyclable catalytic systems that exhibit high activity and stereoselectivity would lessen reliance on the expensive transition-metal catalysts and specially designed chiral phosphine ligands used in many asymmetric Staudinger and Staudinger–aza-Wittig transformations. The goal of extending the scope of substrate classes of newly developed mild methodologies, such as water-free Staudinger reductions, to structurally complex and biologically relevant molecules is also important. Finally, the Staudinger reaction will be increasingly used in conjunction with other efficient synthetic methods, like multicomponent reactions such as the Ugi, Passerini and related tandem reactions, in order to speed up the assembly of medically relevant and structurally complex natural products. Together, these developments will help to build safer, economical and industrially viable Staudinger methodologies for future use in synthetic, medicinal and pharmaceutical chemistry. Artificial intelligence and machine learning in Staudinger reaction research Artificial Intelligence (AI) and Machine Learning (ML) have recently revolutionized the chemical reaction design, optimization, and analysis. While direct use of AI in the Staudinger reaction is scarce, the computational methods offer promising potential for enhancing reaction efficiency, stereoselectivity, and substrate scope. Large reaction databases enable machine learning algorithms to predict the optimal reaction conditions, such as the type of solvent, catalyst, temperature, and other reagents, thus minimizing the need for extensive experimental screening. Such predictive models can also predict yields of reactions and even foresee side reactions before their laboratory implementation.119 Moreover, AI molecular design is an emerging tool in medicinal chemistry, where the compounds made with the Staudinger reaction, such as β-lactams, phosphoramidates, and N-containing heterocycles, can be quickly evaluated for biological activity. The use of molecular docking, molecular dynamics simulations, absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction, quantitative structure–activity relationship (QSAR) analysis, and deep learning models helps prioritize promising candidates prior to synthesis, lowering both cost and time. The recent developments of automated synthesis platforms also highlight the potential of the synergy between AI and continuous flow chemistry and robotics. Such self-optimizing systems can be used to track reaction progress in real time via analytical methods such as LC-MS, NMR or IR spectroscopy, and machine learning algorithms can be run to continuously and automatically update reaction conditions to maximize yield and selectivity. These methods may especially be useful in the synthesis of unstable ketenes, azides, and highly reactive intermediates by Staudinger reactions. Rational design of new catalytic systems and asymmetric transformations can be aided by computational studies supported by AI tools and tools that predict the energies of the transition states, stereochemical outcome and reaction pathways. Summary This review summarizes the evolution of the Staudinger reaction from Hermann Staudinger's original discovery of the ketene–imine [2+2] cycloaddition in 1907 to its development into a versatile and widely applicable synthetic transformation. Particular emphasis is placed on compounds synthesized between 2020 and 2026, highlighting recent advances in methodology, reaction efficiency, stereochemical control, and synthetic scope. Originally developed for the synthesis of β-lactams, the Staudinger reaction has evolved into a powerful platform for the preparation of nitrogen-containing heterocycles, phosphoramidates, and structurally complex alkaloid frameworks. Although the conventional acid chloride/Et3N protocol remains a reliable method for ketene generation, its practical application is limited by handling difficulties and moisture sensitivity. Recent developments, including mixed-anhydride activation using TsCl/DIPEA, photochemical Wolff rearrangement of diazo precursors, and continuous-flow ketene generation, have addressed many of these limitations while maintaining or improving reaction efficiency and diastereoselectivity. Furthermore, the integration of the Staudinger/aza-Wittig sequence has enabled the efficient one-pot synthesis of a wide range of heterocyclic compounds. Despite these advances, several challenges remain, including the dependence of asymmetric methodologies on expensive transition-metal catalysts and specially designed chiral phosphine ligands, such as iridium-, silver-, HypPhos-, and BIBOP-based systems, which often provide only moderate to good enantioselectivities. In addition, the mechanistic roles of newly proposed intermediates, including biradicaloid species and unconventional N–N bond-cleavage pathways, remain incompletely understood. Hence, the century-long development of the Staudinger reaction demonstrates its exceptional versatility, extending from classical azide reduction, asymmetric catalysis, and the construction of biologically important molecules. Future progress will depend on the development of economical metal-free or recyclable catalytic systems, safer one-pot, in situ azide-handling strategies, and comprehensive mechanistic investigations across diverse substrate classes, and the early integration of biological evaluation, including MIC and cytotoxicity studies, with synthetic methodology. Such advances will further strengthen the role of the Staudinger reaction as a practical and sustainable platform in modern synthetic, medicinal, and pharmaceutical chemistry. Author's contributions Ehsan Ullah Mughal: conceptualization, supervision, validation, investigation, resources, data curation, writing – review and editing, visualization, project administration. Nafeesa Naeem: data collection, visualization, validation, formal analysis, investigation, writing – original draft, writing – review and editing. Laiba Iftikhar: data collection, formal analysis, writing – original draft. Shabnam: data collection, formal analysis, writing – original draft. Amina Afzaal: data collection, formal analysis, writing – original draft. H.A. Alrafai: formal analysis, investigation, validation, funding acquisition. Magdi E.A. Zaki: formal analysis, investigation, validation, funding acquisition. Amina Sadiq: formal analysis. Maher Fathalla: formal analysis, investigation, validation, funding acquisition. Conflicts of interest The authors have no conflicts of interest to declare.